erythromycin has been researched along with clarithromycin in 671 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 68 (10.13) | 18.7374 |
| 1990's | 276 (41.13) | 18.2507 |
| 2000's | 185 (27.57) | 29.6817 |
| 2010's | 120 (17.88) | 24.3611 |
| 2020's | 22 (3.28) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, CM; Froshauer, SA; Hayashi, SF; Hecker, SJ; Jaynes, BH; Jefson, MR; Kamicker, BJ; Lipinski, CA; Lundy, KM; McFarland, JW; Reese, CP; Vu, CB | 1 |
| Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Henry, RF; Kim, K; Nilius, AM; Or, YS; Pireh, D; Plattner, JJ; Raney, PM | 1 |
| Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Kramer, MJ; Nilius, AM; Or, YS; Plattner, JJ; Raney, PM | 1 |
| Agouridas, C; Auger, JM; Benedetti, Y; Bonnefoy, A; Bretin, F; Chantot, JF; D'Ambrières, SG; Denis, A; Dussarat, A; Fromentin, C; Lachaud, S; Laurin, P; Le Martret, O; Loyau, V; Tessot, N | 1 |
| Cui, J; Harada, H; Kawase, M; Saito, S; Tani, S | 1 |
| Chu, DT; Clark, RF; Griesgraber, G; Li, L; Ma, Z; Nilius, AM; Or, YS; Tufano, M; Wang, S; Yong, H; Zhang, X | 1 |
| Hasegawa, T; Hui, CS; Kitaichi, K; Miyamoto, KI; Sakai, M; Takagi, K; Wang, L; Yokogawa, K | 1 |
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Asaka, T; Kameo, K; Kashimura, M; Misawa, Y; Morimoto, S; Nishida, A; Sato, M; Suzuki, K; Tanikawa, T | 1 |
| Alder, J; Brazzale, A; Cao, Z; Chu, DT; Clark, RF; Ewing, P; Flamm, R; Griesgraber, G; Li, L; Ma, Z; Meulbroek, J; Mitten, M; Nemoto, PA; Nilius, AM; Or, YS; Phan, LT; Plattner, JJ; Rupp, MJ; Shortridge, VD; Wang, S; Yong, H; Zhang, S; Zhang, X; Zhong, P | 1 |
| Asaka, T; Kameo, K; Kashimura, M; Morimoto, S; Nishida, A; Sato, M; Sugiyama, H; Suzuki, K; Tanikawa, T | 1 |
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Kobayashi, Y; Kohyama, N; Ohbayashi, M; Ohshiro, N; Sakai, R; Yamamoto, T | 1 |
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Mankin, AS; Melman, A; Sherman, D; Xiong, L | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Klugman, KP; Low, DE; Smith, AM; Wolter, N | 1 |
| Kasahara, K; Kita, E; Mikasa, K; Mizuno, F; Nishi, K; Yasuda, Y | 1 |
| Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
| Gibreel, A; Taylor, DE; Wetsch, NM | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chiba, N; Hasegawa, K; Iwata, S; Matsubara, K; Morozumi, M; Nakayama, E; Sunakawa, K; Takayanagi, R; Ubukata, K | 1 |
| Douthwaite, S; Farrell, DJ; Klugman, KP; Northwood, JB; Smith, AM; Wolter, N | 1 |
| Bailey, M; Chettiath, T; Mankin, AS | 1 |
| Hayashi, Y; Ishikawa, C; Konishi, H; Matsuki, M; Mizutani, H; Nakagawa, N; Tsuda, T; Yamanishi, K | 1 |
| Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
| Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
| Arakawa, Y; Kimura, K; Nagano, N; Nagano, Y; Tamai, K; Yanagisawa, H | 1 |
| Bohnert, JA; Fähnrich, E; Kern, WV; Schuster, S; Wehmeier, C | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Baljer, G; Hanssen-Hübner, C; Hunfeld, KP; Kraiczy, P; Morgenstern, K; Norris, DE | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Brown-Elliott, BA; Nash, KA; Wallace, RJ | 1 |
| Jiang, LJ; Or, YS; Wang, M | 1 |
| Blackman Northwood, J; Coley, MD; Cossins, LR; Creti, R; Del Grosso, M; Farrell, DJ; Pantosti, A | 1 |
| Beeton, ML; Chalker, VJ; Kotecha, S; Maxwell, NC; Spiller, OB | 1 |
| Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D | 2 |
| Iwata, S; Murayama, SY; Nakayama, E; Sakata, H; Seki, C; Sunakawa, K; Sunaoshi, K; Ubukata, K | 1 |
| Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, KM; McGhee, P; Nagai, K | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Castanheira, M; Jones, RN; Woosley, LN | 1 |
| Shakya, T; Wright, GD | 1 |
| Liu, Y; Sun, FJ; Wang, Q; Xia, PY; Xie, LL; Xiong, LR | 1 |
| Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Cao, J; Ju, Y; Ma, R; Ma, S; Xian, R; Zhang, L | 1 |
| Mima, T; Schweizer, HP | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Guo, H; He, X; Hu, H; Hu, X; Lu, Y; Luo, M; Pan, Y; Qiu, G; Wu, Z; Xiao, Y; Yang, J; Zhou, D | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Baldelli, R; Cevenini, R; D'Antuono, A; Delucca, F; Di Francesco, A; Donati, M; Moroni, A; Shurdhi, A | 1 |
| Chen, WM; Hu, L; Huang, ZJ; Lan, P; Song, QL; Sun, PH; Wang, Y; Xiao, S; Zhuo, C | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Cui, W; Jiao, B; Ju, Y; Liu, L; Ma, C; Ma, R; Ma, S; Ma, X; Meng, Y; Qi, Y; Shen, X; Wang, H; Zhang, L; Zheng, M | 1 |
| Boothroyd, JC; Choi, JY; Fu, H; Harvey, C; Khosla, C; Lee, Y; Ravindran, S; Roush, WR | 1 |
| Cao, J; Cong, C; Hu, Y; Li, X; Liu, C; Ma, S; Wang, H | 1 |
| Bhateja, P; Chakrabarti, A; Das, B; Dullu, J; Hajare, AK; Jadhav, JS; Kumar, R; Pandya, M; Ramkumar, G; Rathy, S; Surase, YB; Venkataramanan, R | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Houston, JB; Jigorel, E | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, X; Lei, P; Liu, L; Liu, Y; Xu, P; Xu, Y; Zhu, D | 1 |
| Li, X; Ma, S; Wang, Y; Yan, M | 1 |
| Fruziński, A; Gamian, A; Karczmarzyk, Z; Malinka, W; Sliwińska, M; Swiątek, P; Szponar, B | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M | 1 |
| Blanco, MJ; Edmondson, Q; Furukawa, A; Handford, MJ; Hewitt, WM; Kelly, CN; Klein, VG; Lokey, RS; Ly, AM; Naylor, MR; Noland, RP; Pye, CR; Ramos, DP; Schwochert, J; Townsend, CE; Turmon, AC | 1 |
| Bertrand, D; Fernandes, P; Pereira, D; Watkins, PB | 1 |
| Bi, F; Liu, X; Ma, S; Qin, Y; Song, D; Teng, Y; Zhang, N | 1 |
| Augustinović, M; Burdette, JE; Falkinham Iii, JO; Flores-Bocanegra, L; Heath-Borrero, KN; Knowles, SL; Oberlies, NH; Pearce, CJ; Raja, HA; Roberts, CD | 1 |
| Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
| Neu, HC | 2 |
| Danziger, LH; Piscitelli, SC; Rodvold, KA | 1 |
| Brown, BA; De Rosas, V; Onyi, GO; Wallace, RJ | 1 |
| Bahal, N; Nahata, MC | 1 |
| Havlichek, DH; Stein, GE | 1 |
| Tunkel, AR; Whitman, MS | 1 |
| Hammerschlag, MR; Qumei, KK; Roblin, PM | 1 |
| Hedderich, J; Heim, P; Paulsen, P; Peters, O; Simon, C | 1 |
| Stott, GA | 1 |
| Chin, NX; Gu, JW; Neu, HC | 1 |
| Cynamon, MH; Klemens, SP | 1 |
| Peltier, K | 1 |
| Baron, JH; Gummett, PA; Hegarty, BT; Logan, RP; Misiewicz, JJ; Walker, MM | 1 |
| Clissold, SP; Peters, DH | 1 |
| Chen, HY; Maskell, JP; Powell, M | 1 |
| Brown, BA; Onyi, GO; Wallace, RJ | 1 |
| Berk, SL | 1 |
| Azoulay-Dupuis, E; Bédos, JP; Pocidalo, JJ; Vallée, E; Veber, B | 1 |
| Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
| Cavanaugh, J; Chu, SY; Deaton, R | 1 |
| Gonzalez, PC; Hadley, WK; Nassos, PS; Sanders, CA; Yajko, DM | 1 |
| Caccamo, F; de Lalla, F; Marone, P; Maserati, R; Nicolin, R; Rigoli, R; Scarpellini, P | 1 |
| Price, TA; Tuazon, CU | 1 |
| Hamada, K; Kita, E; Konishi, M; Kunimatsu, M; Maeda, K; Masutani, T; Mikasa, K; Sano, R; Sawaki, M; Takeuchi, S | 1 |
| Rapp, RP; Sturgill, MG | 1 |
| Kanno, M; Orikasa, Y; Tejima, E; Watanabe, T | 1 |
| Yajko, DM | 1 |
| Baquero, F; Cantón, R; Garijo, B; León, A; Loza, E; Martínez Beltrán, J | 1 |
| Bersch, R; Pesiri, D; Steinmetz, WE; Towson, J | 1 |
| Guay, DR; Hardy, DJ; Jones, RN | 1 |
| Cavanaugh, JC; Chu, S; Locke, C; Park, Y; Wilson, DS | 1 |
| Araujo, FG; Prokocimer, P; Remington, JS | 1 |
| Comstock, RD; Heifets, LB; Lindholm-Levy, PJ | 1 |
| Craft, JC; Guay, DR | 1 |
| Pohle, HD; Ruf, B; Schürmann, D | 1 |
| Mauch, H; Ruf, B; Schürmann, D | 1 |
| Chonmaitree, T; Hedgpeth, D; Horlick, D; Howie, VM; Owen, MJ; Patel, JA | 1 |
| Bauer, J; Hof, H | 1 |
| Itai, S; Nagai, T; Nakagawa, Y; Yoshida, T | 1 |
| Gelber, RH; Murray, LP; Siu, P; Tsang, M | 1 |
| Felmingham, D; Leakey, A; Ridgway, GL; Robbins, MJ; Sanghrajka, M | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 1 |
| Gikas, A; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 2 |
| Harvengt, C | 1 |
| Anderson, G | 1 |
| Davey, PG | 1 |
| King, A; Phillips, I | 1 |
| Wood, MJ | 1 |
| Aldons, PM | 1 |
| Poirier, R | 1 |
| Hoffman, BM; Olsson-Liljequist, B | 1 |
| Anderson, G; Carnegie, C; Coles, S; Esmonde, TS; Macklin, J | 1 |
| Dabernat, H; Delmas, C; Fourtillan, JB; Girault, J; Lareng, MB; Seguy, M | 1 |
| Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Swanson, R; Vallée, E | 1 |
| Fenelon, L; Mumtaz, G; Ridgway, GL | 1 |
| Cassell, GH; Drnec, J; Duffy, LB; McIntosh, JC; Pate, MS; Waites, KB; Watson, HL | 1 |
| Demartini, G; Dugnani, S; Fraschini, F; Maccarinelli, G; Pintucci, G; Scaglione, F | 1 |
| Levenstein, JH | 1 |
| Bachand, RT | 2 |
| Karma, P; Löth, S; Melén, I; Olén, L; Penttilä, M; Pukander, J; Savolainen, S; Ylikoski, J | 1 |
| Labrousse, V; Rastogi, N | 1 |
| Grosset, JH; Ji, B; Perani, EG | 1 |
| Bachand, RT; Coles, SJ; Millar, ED; O'Neill, SJ | 1 |
| Andrews, JM; Ashby, JP; Logan, MN; Wise, R | 1 |
| Borodkin, S; Diesner, C; Hernandez, L; Li, P; Lu, MY; Vadnere, M; Woodward, L | 1 |
| Brown, DM; Morgan, DK; Plasz, AC; Rotsch, TD | 1 |
| Chen, HY; Powell, M; Weinhardt, B; Williams, JD | 1 |
| Berlie, HC; Chevret, S; Dautzenberg, B; Grosset, J; Legris, S; Mercat, A; Meyohas, MC; Truffot, C | 1 |
| Cugier, P; Plasz, AC; Rotsch, TD; Spanton, M | 1 |
| Howell, AW; Jorgensen, JH; Maher, LA | 1 |
| Grosset, J; Ji, B; Truffot-Pernot, C | 1 |
| Ali, J; Bachand, R; Dawood, G; Hafeez, S; Hamedani, P; Quereshi, S; Raza, R; Yab, Z | 1 |
| Ilic, P; Sprenger, HG; Steensma, JT; van Klingeren, B; Weits, J | 1 |
| Delaval, P; Desrues, B; Kernec, J; Le Coz, A; Lineau, C; Prigent, JM; Quinquenel, ML; Ramee, MP | 1 |
| Chauvin, JP; Fernandez-Martin, J; Leport, C; Meyohas, MC; Morlat, P; Vilde, JL | 1 |
| Gu, JW; Neu, HC; Scully, BE | 1 |
| Brismar, B; Edlund, C; Nord, CE | 1 |
| Furuya, N; Goto, S; Hirakata, Y; Kaneko, Y; Miyazaki, S; Ohno, A; Tateda, K; Tsuji, A; Yamaguchi, K | 1 |
| Christensen, S; Mummaw, N; Stein, GE | 1 |
| Acar, J; Baquero, F; Bergan, T; Forsgren, A; Phillips, I; Wiedemann, B | 1 |
| Barry, AL; Fuchs, PC; Pfaller, MA | 1 |
| Chu, SY; Sennello, LT; Sonders, RC | 1 |
| De Gregoris, P; Fattorini, L; Hu, CQ; Iona, E; Mascellino, MT; Orefici, G; Santoro, C | 1 |
| Bébéar, C; Renaudin, H | 1 |
| Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
| Misawa, Y; Miyachi, J; Morimoto, S; Nagate, T; Numata, K; Omura, S; Ono, T; Sugita, K; Yamada, K | 1 |
| Kohno, Y; Ohta, K; Suga, T; Suwa, T | 1 |
| Marchi, E | 1 |
| Scaglione, F | 1 |
| Asaka, T; Kondoh, H; Misawa, Y; Morimoto, S; Watanabe, Y | 1 |
| Cluzel, M; Derlot, E; Kitzis, MD; Le Van Thoi, J; Soussy, CJ | 1 |
| Bryan, JP; Sheffield, J; Wagner, KF; Waters, C | 1 |
| Clement, JJ; Hardy, DJ; Marsh, K; Rode, RA; Shipkowitz, NL; Swanson, RN | 1 |
| Cacciapuoti, AF; Cramer, CL; Hare, RS; Loebenberg, D; Mallams, AK; Menzel, FW; Miller, GH; Moss, EL; Naples, LR; Rudeen, JA | 1 |
| Wise, R | 2 |
| Beuth, J; Ko, HL; Peters, G; Pulverer, G; Roszkowski, K | 1 |
| Kohno, Y; Suga, T; Suwa, T; Yoshida, H | 2 |
| Buytendorp, M; Faghih, R; Hardy, D; Lartey, P; Plattner, J; Stephens, R | 1 |
| Adachi, T; Morimoto, S | 1 |
| Barrett, MS; Erwin, ME; Jones, RN | 1 |
| Chastang, C; Derouin, F | 1 |
| Baker, WR; Fernandes, PB; Freiberg, LA; Hardy, DJ; McDonald, EJ | 1 |
| Allen, W; Gorzynski, EA; Gutman, SI | 1 |
| Gooch, G; Ho, D; Rolston, K | 1 |
| Baltch, AL; Conroy, JV; Hammer, MC; Liebers, DM; Smith, RP | 1 |
| Kawahira, M; Kobayashi, H; Miura, H; Nakaike, S; Otomo, S; Takeda, H | 1 |
| Abe, T; Arimasu, O; Fujii, R; Higa, A; Hiruma, F; Meguro, H; Shinozaki, T; Sugamata, K; Sugie, N | 1 |
| Akita, H; Iwata, S; Sato, Y; Sunakawa, K | 1 |
| Matsumoto, K; Nakanishi, Y; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H | 1 |
| Iwai, N; Kasai, K; Miyazu, M; Nakamura, H; Taneda, Y | 1 |
| Hayakawa, F; Ishikawa, H; Kimura, H; Kuno, K; Nakao, Y; Takeuchi, H; Yamamoto, N | 1 |
| Iguchi, K; Kamiya, H; Kawaguchi, H; Sakurai, M | 1 |
| Ito, S; Mayumi, M; Mikawa, H | 1 |
| Aoki, S; Nishimura, T; Tabuki, K; Takagi, M | 1 |
| Adachi, Y; Hattori, K; Higashino, H; Kobayashi, Y; Nobori, U; Sato, Y; Takebe, A; Takedatsu, M; Tanaka, H; Uh, M | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Ohkura, K; Tsutsui, T | 1 |
| Hosoda, T; Ichioka, T; Miyao, M; Tayama, M | 1 |
| Hayashi, M; Kida, K; Matsuda, H; Murase, M | 1 |
| Araki, K; Kubota, H; Kurashige, T; Nomura, I; Ogura, H; Ogura, Y; Tomoda, T | 1 |
| Kozan, S; Miyazaki, M; Nishimori, M; Ohara, K; Okamoto, T; Sekiguchi, T | 1 |
| Furukawa, S; Okada, T | 1 |
| Aramaki, M; Fujimoto, T; Kawakami, A; Koga, T; Kuroiwa, Y; Motohiro, T; Oda, K; Sakata, Y; Shimada, Y; Tanaka, K | 1 |
| Aramaki, M; Kawakami, A; Koga, T; Motohiro, T; Oda, K; Sakata, Y; Sasaki, H; Shimada, Y; Tanaka, K; Yoshinaga, Y | 1 |
| Imamura, H; Nakayama, N; Tsuji, Y; Yanagi, T; Yanagishima, M; Yanai, M | 1 |
| Abe, T; Arimasu, O; Fujii, R; Higa, A; Hiruma, F; Meguro, H; Shinozaki, T; Sugamata, K; Sugie, N; Sunagawa, K | 1 |
| Descatoire, V; Labbe, G; Larrey, D; Letteron, P; Loeper, J; Pessayre, D; Tinel, M | 1 |
| Kaneko, A; Kobayashi, I; Kohno, Y; Morihana, T; Suwa, T; Tomita, F | 1 |
| Ikeshima, K; Morihana, T; Morishima, T; Noma, H; Sakamoto, H; Sasaki, J; Shiiki, K; Takai, H; Tomita, F; Uematsu, M | 1 |
| Adachi, T; Omura, S; Sasaki, J | 1 |
| Dotsu, Y; Hayashi, T; Hirota, M; Inoue, Y; Koga, H; Kohno, S; Masaki, M; Masuyama, Y; Saito, A; Yamaguchi, K | 1 |
| Fernandes, PB; Hanson, CW; Hardy, DJ; McDaniel, D; Swanson, RN | 1 |
| Harada, M; Mizushima, Y; Nakagawa, T; Otomo, S; Takeshita, K; Yamagishi, I | 1 |
| Gross, B; Preac-Mursic, V; Schierz, G; Süss, E; Wilske, B | 1 |
| Eichhorn, A; Hoppe, JE | 1 |
| Adachi, T; Iwasaki, H; Kamiya, N; Morimoto, S; Watanabe, Y | 1 |
| Chang, HR; Pechère, JC | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 3 |
| Bailer, R; Bower, RR; Fernandes, PB; Gade, E; Hanson, CW; Hardy, D; McDonald, E; Ramer, N; Shipkowitz, N; Swanson, R | 1 |
| Kapell, KS; Kessler, HA; Segreti, J; Trenholme, GM | 1 |
| Beaudette, FE; Benson, CA; Goodman, LJ; Hines, DW; Kaplan, RL; Segreti, J; Trenholme, GM | 1 |
| Gilligan, PH; Hodinka, RL; Jack-Wait, K | 1 |
| Chin, NX; Labthavikul, P; Neu, HC; Neu, NM; Saha, G | 1 |
| Black, WA; Bowie, WR; Chan, DG; Shaw, CE | 1 |
| Benson, C; Goodman, L; Hines, D; Kaplan, R; Kessler, H; Segreti, J; Trenholme, G | 1 |
| Bailer, R; Fernandes, PB; Gade, E; Hanson, CW; Rode, RA | 1 |
| Floyd-Reising, S; Hindler, JA; Young, LS | 1 |
| Barry, AL; Jones, RN | 1 |
| Bailer, R; Fernandes, PB; Gade, E; Hardy, D; McDonald, E; Pintar, J; Ramer, N; Swanson, R | 1 |
| Berlin, OG; Bruckner, DA; Floyd-Reising, SA; Young, LS | 1 |
| Finegold, SM; Wexler, HM | 1 |
| Jansson, L; Kalin, M | 1 |
| Dette, GA; Knothe, H; Koulen, G | 1 |
| Eliopoulos, GM; Ferraro, MJ; Moellering, RC; Reiszner, E | 1 |
| Fernandes, PB; Freiberg, L; Ramer, N; Rode, RA | 1 |
| Baltch, AL; Conroy, JV; Hammer, MC; Liebers, DM; Shayegani, M; Smith, RP | 1 |
| Adachi, T; Mizoue, K; Morimoto, S; Omura, S; Sasaki, J | 1 |
| Adachi, T; Kondoh, H; Morimoto, S; Nagate, T; Sota, K; Watanabe, Y | 1 |
| Chang, HR; Pechère, JC; Rudareanu, FC | 1 |
| Canupp, KC; Cassell, GH; Fernandes, PB; Waites, KB | 1 |
| Chi, SJ; Maskell, JP; Sefton, AM; Williams, JD; Yong, FJ | 1 |
| Barry, AL; Fernandes, PB; Hardy, DJ; Jones, RN; Jorgensen, JH; Thornsberry, C | 1 |
| Fernandes, PB; Hardy, DJ; McDonald, EJ; Ramer, N; Swanson, RN | 1 |
| Anderson, R; Joone, G; van Rensburg, CE | 1 |
| Dunnigan, DA; Freiberg, LA; Horlock, PL; Liss, RH; Palmer, AJ; Perun, TJ; Pike, VW | 1 |
| Morimoto, S; Omura, S; Takahashi, Y; Watanabe, Y | 1 |
| Abruzzo, GK; Bartizal, K; Flattery, AM; Gill, CJ; Jackson, J; Kong, L; Kropp, H; Shankaran, K; Smith, JG; Wilkening, R | 1 |
| Mouton, RP; Sloos, JH; Van Asselt, GJ; Van Boven, CP; Van de Klundert, JA | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 2 |
| Millesimo, M; Savoia, D | 1 |
| Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
| Carreres, A; Domingo, C; Roig, J | 1 |
| Konno, K; Sakai, A; Tagaya, E; Tamaoki, J | 1 |
| Conte, JE; Duncan, S; Golden, JA; McKenna, E; Zurlinden, E | 1 |
| Cederbrant, G; Kahlmeter, G; Kamme, C; Schalén, C | 1 |
| Kuwayama, H; Nakajima, M; Sunairi, M; Suzuki, T; Tanaka, N; Watanabe, K | 1 |
| Fung, CP; Jang, TN; Liu, CY; Wang, FD; Yang, SP | 1 |
| Boustany, RM; DeLong, GR; Loganbill, H; Nahouraii, R; Nohria, V; Stafstrom, CE | 1 |
| Echávarri, B; Marco, ML; Remacha, A | 1 |
| Goodman, NL; McCraney, SA; Rapp, RP; Shaddick, DJ | 1 |
| Doern, GV; Erwin, ME; Gerlach, EH; Hindler, J; Jones, RN | 1 |
| Beyer, J; Capobianco, J; Flamm, R; Goldman, RC; Zakula, D | 1 |
| Hammerschlag, MR; Montalban, G; Roblin, PM | 1 |
| Irifune, K; Ishida, K; Kaku, M; Mizukane, R; Suyama, N; Takemura, H; Tanaka, H; Tomono, K; Usui, T; Yoshida, R | 1 |
| Maurin, M; Raoult, D | 1 |
| Bustos, R; Herrera, N; Marinkovic, K; Prado, V; Romero, J | 1 |
| Barbour, AG; Dever, LL; Jorgensen, JH | 1 |
| Lonks, JR; Medeiros, AA | 1 |
| Fass, RJ | 1 |
| Narita, N | 1 |
| Parish, LC | 1 |
| Adachi, T; Asaka, T; Kashimura, M; Matsunaga, T; Morimoto, S; Watanabe, Y | 1 |
| Holdcroft, C | 1 |
| Vaara, M | 1 |
| Hammerschlag, MR | 2 |
| Eliopoulos, GM; Ferraro, MJ; Malanoski, GJ; Moellering, RC | 1 |
| Ikerd, TR; Koletar, SL | 1 |
| Ellis, W; Fayer, R | 1 |
| Guzmán, CA; Molinari, G; Pesce, A; Schito, GC | 1 |
| Müller, O | 1 |
| Bradbury, F | 1 |
| Baskerville, A; Fitzgeorge, RB; Lever, S | 1 |
| Cimochowski, CR; Faiella, JA; Girard, AE | 1 |
| Chan, CK; Chien, SM; Pichotta, P; Siepman, N | 1 |
| Adachi, T; Asaka, T; Kashimura, M; Morimoto, S; Watanabe, Y | 1 |
| Doucet-Populaire, F; Grosset, J; Jarlier, V; Truffot-Pernot, C | 1 |
| Hosie, J; Quinn, P; Sides, G; Smits, P | 1 |
| Cluzel, R; Philippon, A; Soussy, CJ | 1 |
| Pocidalo, JJ; Veber, B | 1 |
| Oster, G; Thompson, D | 1 |
| Iwakawa, S; Komada, F; Ohba, M; Ohnishi, N; Okumura, K | 1 |
| Gaydos, C; Quinn, TC; Welsh, L | 1 |
| Barrett, MS; Jones, RN; Mehaffey, PC; Putnam, SD | 1 |
| Appelbaum, PC; Ednie, LM; Jacobs, MR; Visalli, MA | 1 |
| O'Hara, K; Yamamoto, K | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Vermot, D; Vouillamoz, J | 1 |
| Fujita, J; Hojo, S; Kawanishi, K; Negayama, K; Takahara, J; Xu, G; Yamaji, Y; Yuube, K | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| Tuominen, RK; Vainio, PJ; Viluksela, M | 1 |
| Furuya, N; Ishii, Y; Matsumoto, T; Matsunaga, T; Miyazaki, S; Nagashima, M; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
| Citron, DM; Claros, MC; Goldstein, EJ; Hunt Gerardo, S | 1 |
| Abdel-Rahman, SM; Nahata, MC; Wintermeyer, SM | 1 |
| Flurer, CL | 1 |
| Kapell, K; Meyer, P; Segreti, J | 1 |
| Ichiman, Y; Ohshima, Y; Ohtomo, T; Shimada, J; Usui, Y; Yanagisawa, N; Yokota, E | 1 |
| Adachi, T; Fukuda, T; Hirata, A; Kihara, N; Kosaku, A; Makino, S; Motojima, S; Ohtake, H | 1 |
| Anderson, R; Feldman, C; Theron, AJ | 1 |
| Braga, PC; Brenciaglia, MI; Fornara, AM; Scaltrito, MM | 1 |
| Berg-Candolfi, M; Candolfi, E | 1 |
| Bermejo, M; García-de-Lomas, J; García-Ponte, L; Garijo, B; Gimeno, C; Lázaro, MA; Millás, E; Navarro, D | 1 |
| Gorodnitzky, Z; Korenman, Z; Weiss, I; Yagupsky, P | 1 |
| Konishi, T; Nakao, M | 1 |
| Hamada, K; Kita, E; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S | 1 |
| Kato, A | 1 |
| Fietta, A; Gialdroni Grassi, G; Merlini, C | 1 |
| Klein, JO | 1 |
| McCracken, GH | 1 |
| Tarlow, MJ | 1 |
| Arimori, K; Nakamura, K; Nakano, M; Tsuruta, S | 1 |
| Andrews, JM; Boswell, F; Brenwald, NP; Wise, R | 1 |
| Buckley, M; Keane, CT; O'Morain, CA; Xia, HX | 1 |
| Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
| Ortiz, JA; Palacín, C; Sacristán, A; Tarragó, C | 1 |
| Vagliasindi, M | 1 |
| Akashi, T; Hoshikawa, Y; Kanegasaki, S; Nakata, K; Sakai, A; Tanaka, N; Tozu, T | 1 |
| Hoppe, JE; Tschirner, T | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 2 |
| Brandt, CM; Miro, JM; Patel, R; Rouse, MS; Steckelberg, JM; Wilson, WR | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 2 |
| Appelbaum, PC; Ednie, LM; Jacobs, MR | 2 |
| Clark, RF; Kundu, S; Nordt, SP; Williams, SR | 1 |
| Furuno, T; Hara, N; Hidaka, K; Mitsuyama, T | 1 |
| Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC | 1 |
| Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
| Iino, S; Iwasawa, H; Nakashio, S; Shimada, J | 1 |
| Colodner, R; Keness, Y; Raz, R; Sakran, W | 1 |
| Ge, Z; Hiratsuka, K; Lo, T; Purych, D; Taylor, DE | 1 |
| Bell, JM; Grayson, ML; Lambert, JR; Midolo, PD; Turnidge, JD | 1 |
| Laufen, H; Schumacher, T; Yeates, RA; Zimmermann, T | 1 |
| Hashiba, M; Kondoh, K | 1 |
| Capobianco, JO; Doucet-Populaire, F; Goldman, RC; Jarlier, V; Zakula, D | 1 |
| Arnold, B; Stout, JE; Yu, VL | 1 |
| Bryskier, A; Hoppe, JE | 1 |
| Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 1 |
| Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK | 1 |
| Inoue, K; Matsuo, H; Sakamoto, Y; Sakata, K; Shibazaki, M; Tanaka, K | 1 |
| Goto, G; Ieshiro, R; Iguchi, M; Okamura, J; Ota, T; Yuasa, K | 1 |
| Furukawa, M; Ikeda, K; Shimomura, A; Suzuki, H; Takasaka, T; Wataya, H | 1 |
| Kobayashi, H; Kobayashi, O; Ota, M; Watanabe, H | 1 |
| Baba, S; Hashiba, M; Kondo, K | 1 |
| Haruta, Y; Ishioka, S; Mineshita, M; Tei, A; Yamakido, M | 1 |
| Fujii, T; Iida, K; Kadota, J; Kaseta, M; Kawakami, K; Kawamoto, T; Kawano, S; Matsubara, Y; Shirai, R; Taniguchi, H | 1 |
| Hori, S; Kawamura, M; Sato, J | 1 |
| Furuno, T; Hara, N; Hidaka, T; Hikariyama, T; Ishibashi, B | 1 |
| Gunwa, H; Isono, K; Kondo, M; Nagai, A; Nishimura, K; Tamaoki, J | 1 |
| Honma, S; Kawabata, M; Kishi, K; Nakada, K; Nakatani, R; Narui, K; Tsuboi, N | 1 |
| Iino, Y; Kakinuma, M; Kishimoto, H; Miyazawa, T; Ogawa, K; Shiga, J | 1 |
| Abe, S; Kato, S; Nakamura, H; Takeda, H; Tomoike, H | 1 |
| Ito, K; Kawasaki, S; Koyama, T; Otoshi, T; Takami, K; Takizawa, H | 1 |
| Matsushima, K; Nagatake, T; Oishi, K; Omura, T; Yoshimine, H | 1 |
| Baba, S; Hashiba, M; Kozeki, S; Miyamoto, N; Suzuki, K | 1 |
| Akashi, T; Kanegasaki, S; Nakada, M; Tanaka, N; Totsu, T | 1 |
| Isono, K; Kondo, M; Kyo, S; Nagai, A; Tamaoki, J | 1 |
| Hunzelmann, N; Krieg, T; Kruppa, A; Scharffetter-Kochanek, K | 1 |
| Hoshino, K; Iwai, Y; Nakamura, S; Seto, I; Yamaguchi, K | 1 |
| Hasegawa, Y; Imai, C; Nakae, M; Osaka, K; Sasaki, H; Shibasaki, K; Sugahara, Y; Yasui, H | 1 |
| Enomoto, F; Ichikawa, G; Kin, R | 1 |
| Furukawa, M; Ikeda, K; Takasaka, T; Yamatani, M | 1 |
| Desaki, M; Ito, K; Kawasaki, S; Kohyama, T; Nakajima, J; Ohtoshi, T; Sato, M; Takizawa, H; Yanagisawa, M | 1 |
| Barg, N | 1 |
| Hirakata, Y; Igari, J; Kaku, M; Matsuda, J; Misawa, N; Mori, T; Murase, M; Nakamura, A; Nakamura, Y; Oguri, T; Shimada, J; Shimoura, M; Shitara, M; Tachibana, Y; Tazawa, S; Ugajin, K; Umezu, S | 1 |
| Counihan, M; Duan, SX; Durol, AL; Graf, JA; Greenblatt, DJ; Harmatz, JS; Mertzanis, P; Shader, RI; von Moltke, LL; Wright, CE | 1 |
| Catamo, G; Di Bonaventura, G; Piccolomini, R | 1 |
| Burdine, R; Champney, WS | 1 |
| Berry, V; Knott, SJ; Thorburn, CE; Woodnutt, G | 1 |
| Baquero, F; Bermejo, F; Boixeda, D; Cantón, R; de Rafael, L; García-Arata, MI; Gisbert, JP; Martín de Argila, C | 1 |
| Esposito, S; Principi, N | 1 |
| Bermejo, M; Díez, J; García de Lomas, J; García-Ponte, L; Gimeno, C; Navarro, D | 1 |
| Mazzei, T; Periti, P | 1 |
| Desaki, M; Obata, R; Omura, S; Otoguro, K; Sunazuka, T; Suzuki, K; Takizawa, H | 1 |
| Akiyama, N; Ito, K; Kawasaki, S; Kohyama, T; Sato, M; Takizawa, H | 1 |
| Amsden, GW; McConnell, SA | 1 |
| Dubois, J; St-Pierre, C | 1 |
| Champney, WS; Tober, CL | 1 |
| Cannon, BM; Conerly, LL; Dajcs, JJ; Hill, JM; Hume, EB; Moreau, JM; O'Callaghan, RJ | 1 |
| Alvarez-Elcoro, S; Enzler, MJ | 1 |
| Kouppari, G; Mavroidi, A; Tzelepi, E; Tzouvelekis, LS; Zaphiropoulou, A | 1 |
| Hill, SL; Johnson, MM; Piddock, LJ | 1 |
| Appelbaum, PC; Credito, KL; Ednie, LM; Jacobs, MR | 1 |
| Boyanova, L; Docheva, J; Koumanova, R; Krastev, Z; Mitov, I; Petrov, S; Spassova, Z; Stancheva, I | 1 |
| Furunishi, M; Kita, E; Maeda, K; Mashima, T; Mikasa, K; Narita, N; Sakamoto, M; Ueta, K | 1 |
| Moore, PA | 1 |
| Bailey, TC; Frisse, ME; McMullin, ST; Reichley, RM; Steib, SA; Watson, LA | 1 |
| Furuta, T; Yoshida, H | 1 |
| Frimpong, EK; Honda, T; Voravuthikunchai, SP; Yoh, M | 1 |
| Grieme, T; Ku, YY; Nilius, A; Riley, D | 1 |
| Carnuccio, R; D'Acquisto, F; Di Rosa, M; Ialenti, A; Ianaro, A; Iuvone, T; Maffia, P; Rombolà, L; Sautebin, L | 1 |
| Allevi, P; Anastasia, M; Longo, A | 1 |
| Barber, J; Boote, V; Mordi, MN; Morris, GA; Pelta, MD | 1 |
| Aoshiba, K; Kohri, K; Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J | 1 |
| Brophy, DF; Chittick, GE; Gillotin, C; Israel, DS; Lou, Y; Pastor, A; Polk, RE; Sadler, BM; Symonds, WT | 1 |
| Iino, Y; Miyazawa, T | 1 |
| Iwai, J; Kobata, R; Obori, M; Omura, S; Otoguro, K; Sunazuka, K; Suzuki, K | 1 |
| Dezaki, S; Morita, K; Takizawa, H; Yamamoto, K | 1 |
| Douthwaite, S; Hansen, LH; Mauvais, P | 1 |
| Goss, TF; Najib, MM; Stein, GE | 1 |
| Matsumoto, A; Matsushima, T; Miyashita, N | 1 |
| Fujita, K; Majima, Y; Sakakura, Y; Shimizu, T | 1 |
| Hatipoglu, ON; Tasan, Y | 1 |
| Komine, M; Tamaki, K | 1 |
| Carter, JL; Cynamon, MH; Shoen, CM | 1 |
| Douya, R; Mushiroda, T; Nagata, O; Takahara, E | 1 |
| Westphal, JF | 1 |
| McWhinney, PH; Ragunathan, PL; Rowbottham, TJ | 1 |
| Asaoka, N; Honda, Y; Ohba, H; Okimoto, N; Osaki, K; Soejima, R; Sunagawa, T; Yoneyama, H | 1 |
| Esposito, S; Ianniello, F; Noviello, S | 1 |
| de Dios García-Díaz, J; Moreno-Vázquez, M; Paz Martínez Ortega, M; Santolaya Perrín, R | 1 |
| Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A | 1 |
| Garvin, CG; Martin, SJ; McBurney, CR; Sahloff, EG | 1 |
| Dan, M; Rosenberg, S; Samra, Z; Soffer, Y | 1 |
| Almer, L; Beyer, J; Bui, MH; Flamm, RK; Hensey-Rudloff, D; Ma, Z; Nilius, AM; Or, YS | 1 |
| Miller, SD | 1 |
| Komiya, N; Tamaoki, K | 1 |
| Katayama, I; Matsunaga, Y; Monden, J | 1 |
| Enomoto, F; Fujimori, M; Ichikawa, G; Kim, R; Okazoe, S | 1 |
| Lanxiang, Y; Shengxi, C; Xiandong, X | 1 |
| Bouvet, A; Broc, V; Merad, B; Rostane, H; Schlegel, L | 1 |
| Adali, MK; Karasalihoglu, AR; Koten, M; Uzun, C; Yagiz, R; Yorulmaz, F | 1 |
| Nakahata, T; Nakamura, Y; Tamari, M; Yamanaka, Y | 1 |
| Appelbaum, PC; Bryskier, A; Davies, TA; Ednie, LM; Jacobs, MR; Nagai, K; Palavecino, E | 1 |
| Lebel, MH; Mehra, S | 1 |
| Peters, G; von Eiff, C | 1 |
| Fujiwara, Y; Fukui, S; Ito, T; Izumiyama, N; Kashima, M; Miura, M; Sano, M; Sasaki, M; Watanabe, A | 1 |
| Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Kanemitsu, K; Kunishima, H; Shimada, J; Takemura, H; Yamamoto, H | 1 |
| Gaylor, AS; Reilly, JC | 1 |
| Bathgate, T; King, A; Phillips, I | 1 |
| Conroy, MC; Emond, JP; Fauchère, JL; Glupczynski, Y; Grignon, B; Husson, MO; Loulergue, J; Mégraud, F; Raymond, J; Tankovic, J | 1 |
| Braga, PC | 1 |
| Anatoliotaki, M; Anatoliotakis, N; Apostolakou, H; Kontoyiannis, DP; Maraki, S; Margioris, AN; Samonis, G; Tselentis, Y | 1 |
| Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J | 1 |
| Amat, C; Ancelin-Malbreil, E; Becquart, JP; Faulques, B; Michault, A; Picot, S; Sapin, G; Simac, C | 1 |
| Blondeau, JM | 1 |
| Sugiyama, Y | 1 |
| Kanai, H; Maizumi, N; Tamura, Y; Tsutsui, T | 1 |
| Biertz, J; Breithardt, G; Bruns, HJ; Eckardt, L; Fabritz, L; Fleischer, D; Haverkamp, W; Kirchhof, P; Milberg, P; Ramtin, S; Reinsch, N | 1 |
| Kotegawa, T; Kuranari, M; Matsuki, S; Morimoto, T; Nakano, S; Otani, Y; Tsutsumi, K | 1 |
| Chuah, SK; Gollapudi, S; Iskandar, L; Thadepalli, H | 1 |
| Hamabe, M; Higaki, K; Kimura, T; Kubo, JI; Ogawara, KI; Ohigashi, Y; Saito, H | 1 |
| Eiros, JM; Mayo, A; Pastor, E | 1 |
| Iikura, H; Odashima, Y; Takamura, M | 1 |
| Hozawa, T | 1 |
| Aoshiba, K; Isono, K; Kondo, M; Nagai, A; Nakata, J; Takeyama, K; Tamaoki, A | 1 |
| Majima, Y; Shimizu, S; Shimizu, T | 1 |
| Maeda, K; Nakaya, Y; Shinkawa, K; Sone, S; Takahashi, A; Tanoue, N | 1 |
| Fujiwara, Y; Fukui, S; Ito, T; Izumiyama, N; Kashima, M; Miura, H; Sano, M; Sasaki, M | 1 |
| Maeda, K; Mikasa, K | 1 |
| Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
| Arrigucci, S; Cassetta, MI; Fallani, S; Mazzei, T; Novelli, A | 1 |
| Al-Khatib, SM; Allen LaPointe, NM; Califf, RM; Curtis, LH; Dans, PE; Hutchison, S; Schulman, KA; Sendersky, V; Usdin Yasuda, S; Woosley, RL; Wright, A; Østbye, T | 1 |
| Baughman, AL; Bisgard, KM | 1 |
| Connell, SR; Dinos, GP; Kalpaxis, DL; Nierhaus, KH | 1 |
| Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H | 1 |
| Abe, S; Inoue, S; Nakamura, H; Otake, K; Sada, M; Takeda, H | 1 |
| Amano, H; Dobashi, Y; Nagatake, T; Oishi, K; Yamaryo, T; Yoshimine, H | 1 |
| Azuma, A; Kudoh, S | 1 |
| Quinn, J; Ruoff, GE; Ziter, PS | 1 |
| Casal, M; Gordillo, RM; Ibarra, A; Lacasa, MJ; Rodríguez, F | 1 |
| Ito, K; Itoh, T; Kanamitsu, S; Ogihara, K | 1 |
| Schöni, MH | 1 |
| Badaró, R; Bumroongkit, C; Corrêa, JC; Dolmann, AL; Juárez Martínez, LG; Mayrinck, LR; Mera, JR; Tamez, R; Yang, JY | 1 |
| Amyes, S; Walsh, F; Willcock, J | 1 |
| Chronopoulou, G; Foustoukou, M; Ioannidou, S; Kanavaki, S; Kanelopoulou, M; Pangalis, A; Papafraggas, E; Petropoulou, N; Salem, Z; Tassios, PT; Trikka-Graphakos, E; Vatopoulos, AC; Zachariadou, L | 1 |
| Fujiki, Y; Iyobe, S; Okubo, T; Sagai, H | 1 |
| Alvirez-Freites, E; Cynamon, MH; DeStefano, MS; Yeo, AE | 1 |
| Agrawal, KC; Carlton, CG; Clarkson, CW; Crumb, WJ; Stanat, SJ | 1 |
| Ninomiya, K | 1 |
| Abe, S; Kubota, I; Sada, M; Shibata, A; Takabatake, N; Takeda, H | 1 |
| Amano, H; Nagatake, T; Oishi, K; Yamamine, T | 1 |
| Inoue, K; Kumakura, S; Tsutsui, T; Uchida, M | 1 |
| Baysallar, M; Doğanci, L; Gür, D; Senses, Z | 1 |
| Appelbaum, PC; Bozdogan, B; Galderisi, C; Krissinger, D; Peric, M; Rager, T | 1 |
| Buxbaum, A; Gattringer, R; Georgopoulos, A; Graninger, W; Lagler, H; Sauermann, R; Stich, K | 1 |
| Champney, WS; Eller, J; Mabe, S | 1 |
| Bagnardi, V; Botteri, E; Carobbio, A; Corrao, G; Falcone, C; Leoni, O; Zambon, A | 1 |
| Bingen, E; Brahimi, N; Deforche, D; Doit, C; Francois, M; Mariani-Kurkdjian, P; Van den Abbeele, T | 1 |
| Appelbaum, PC; Bozdogan, B; Clark, CL; Credito, KL; Ednie, LM; Jacobs, MR; Kelly, LM; Kosowska, K; Lin, G; Matic, V; McGhee, P; Pankuch, GA; Smith, K | 1 |
| Appelbaum, PC; Clark, C; Credito, K; Dewasse, B; Hoellman, D; Jacobs, MR; Kosowska, K; Lin, G; McGhee, P; Pankuch, GA | 1 |
| Amsden, GW | 1 |
| Bowie, WR; Hutchinson, JM; Marra, F; Ng, H; Patrick, DM; White, R | 1 |
| Ishii, K; Itai, S; Nagai, T; Nemoto, M; Saito, Y; Takayama, K | 1 |
| Altunaiji, S; Curtis, N; Kukuruzovic, R; Massie, J | 2 |
| Shen, XZ; Wang, YH; Yang, H; Yang, YH; Yu, SJ; Yuan, L | 1 |
| García Vázquez, E; Marcos, MA; Martínez, JA; Mensa, J; Ortega, M; Puig, J; Torres, A | 1 |
| Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH | 1 |
| Kasahara, K; Kimura, H; Kita, E; Konishi, M; Maeda, K; Mikasa, K; Murakawa, K; Uno, K; Yoshimoto, E | 1 |
| Bosnar, M; Eraković, V; Kelnerić, Z; Munić, V; Parnham, MJ | 1 |
| Balatsouras, DG; Homsioglou, E; Kouskoukis, C; Rallis, E; Verros, C | 1 |
| Mikasa, K | 1 |
| Lee, WK; Young, BW | 1 |
| Bolla, JM; Mamelli, L; Mégraud, F; Pagès, JM; Prouzet-Mauléon, V | 1 |
| Burt, H; Galetin, A; Gibbons, L; Houston, JB | 1 |
| Choi, KI; Kang, TW; Nam, G; Shin, JH | 1 |
| Moran, J; Murphy, TV; Tiwari, T | 1 |
| Cofré Guerra, J | 1 |
| Høgh, B; Pontoppidan, PE | 1 |
| Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T | 1 |
| Boswinkel, M; Sloet van Oldruitenborgh-Oosterbaan, MM | 1 |
| Halling, SM; Jensen, AE | 1 |
| Ito, S; Murakami, H; Nasu, R; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
| Hosoya, M; Katayose, M; Kato, K; Kawasaki, Y; Matsumoto, A; Suzuki, H | 1 |
| Inoue, M; Kaneko, K; Sato, Y | 1 |
| Blasi, F; de Caprariis, PJ; Feldman, C; Garbino, J; Hoepelman, IM; Hogan, P; Tamm, M; Todisco, T | 1 |
| Giguère, S; Lee, EA; Suarez-Mier, G | 1 |
| Andersson, KS; Molden, E | 1 |
| Ferekidis, E; Maragoudakis, P; Nikolopoulos, TP; Tzagaroulakis, A; Vlastarakos, PV | 1 |
| Aoki, A; Inoue, M; Iyobe, S; Kobayashi, T; Nakada, Y; Okitsu, N; Sagai, H; Toriya, M; Yano, H | 1 |
| Adelman, MH; Chiou, CC; Klugman, KP; Lavin, B; Paladino, JA; Patel, M; Schentag, JJ; Wilton, GJ; Yu, VL | 1 |
| Aono, Y; Azuma, M; Inayama, M; Izumi, K; Kinoshita, K; Kishi, J; Makino, H; Nishioka, Y; Ogushi, F; Shono, M; Sone, S; Uehara, H | 1 |
| Arguedas, A; Blumer, JL; Bradley, JS; Melkote, R; Noel, GJ; Sáez-Llorens, X | 1 |
| Heinämäki, J; Miroshnyk, I; Mirza, S; Yli-Kauhaluoma, J; Yliruusi, J; Zorky, PM | 1 |
| Cervin, A; Wallwork, B | 1 |
| Gómez-Tembleque, P; Laguna-Martínez, JJ; Reaño-Martos, M; Rojo-Andrés, E; Sánchez-Morillas, L; Santaolalla-Montoya, M | 1 |
| Pedersen, JA; Sibley, SD | 1 |
| Chen, JM; Huang, LM; Lee, CY; Lee, PI; Wu, MH | 1 |
| Bukhari, IA | 1 |
| Ando, S; Inoue, M; Kishimoto, T; Ogawa, M; Sato, K; Takemura, H; Yamazaki, T | 1 |
| Jin, ZP; Lei, PS; Li, Y; Liu, J; Liu, L; Wang, GQ; Xu, P | 1 |
| Chee, YJ; Jung, HC; Kim, IY; Kim, JM; Kim, JS; Kim, N; Kim, YJ; Lee, CH | 1 |
| Hidaka, H; Kubota, T; Kubuta, T; Nakao, Y; Nishio, N | 1 |
| Burgmann, H; Georgopoulos, A; Kollaritsch, H; Kundi, M; Paulke-Korinek, M; Rendi-Wagner, P; Vécsei, A | 1 |
| Alexander, RE; Grogan, DM | 1 |
| Chen, XZ; Jin, ZP; Lei, PS; Li, Y; Liu, J; Liu, L; Wang, GQ; Xu, P | 1 |
| Marchetti, F; Patarino, F; Tornese, G | 1 |
| Avolio, M; Camporese, A; De Rosa, R; Modolo, ML; Stano, P | 1 |
| Gomes, T; Juurlink, DN; Mamdani, MM | 1 |
| Davis, CB; Dawson, PA; Garver, E; Han, C; Haywood, J; Lan, T; Rao, A | 1 |
| Finley, R; Glass, SK; McEwen, SA; Pearl, DL | 1 |
| Fukuchi, Y; Ichinose, M; Kudo, S; Seemungal, TA; Yamatani, M | 1 |
| Bruckner, AL; Kim, J; Martinez-Diaz, GJ | 1 |
| Duncan, J; Fry, NK; George, RC; Harrison, TG; Vaghji, L | 1 |
| Tang, D; Ying, L | 1 |
| Giguère, S; Javsicas, LH; Womble, AY | 1 |
| Hasan, SM; Hassan, F; Khan, NW; Naqvi, BS | 1 |
| Gomes, T; Horn, JR; Juurlink, DN; Mamdani, MM; Wright, AJ | 1 |
| Anić-Milić, T; Bogdan, M; Bosnar, M; Culić, O; Eraković Haber, V; Marjanović, N; Michielin, F; Parnham, MJ; Popović-Grle, S; Willé, DR | 1 |
| Dan, M; Rosenberg, S; Samra, Z | 1 |
| Del Mar, CB; Doust, J; Eriksson, L; Spurling, GK | 1 |
| Ashley, EA; Lubell, Y; Turner, P; White, NJ | 1 |
| Ghosh, SK; Osman, M | 1 |
| Avci, O; Kusku, E; Tanyildizi, T | 1 |
| Wang, CP; Xu, XL; Zeng, XH; Zhou, M; Zhou, Y | 1 |
| Bencetić Mihaljević, V; Letfus, V; Milić, A; Padovan, J; Ralić, J | 1 |
| Walkey, AJ; Wiener, RS | 1 |
| Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R | 1 |
| Baba, T; Kadono, K; Kanazu, T; Sato, N; Takeda, Y; Touchi, A; Yamaguchi, Y | 1 |
| Itakura, S; Kamiya, S; Kouyama, T; Nagase, T; Omura, S; Sunazuka, T; Takizawa, H; Yamauchi, Y | 1 |
| Abe, S; Inoue, S; Kimura, T; Kubota, I; Shibata, Y; Takabatake, N; Yamauchi, K | 1 |
| Yamaya, M | 2 |
| Noto, MJ; Wheeler, AP | 1 |
| Avila-Campos, MJ; Finegold, SM; Liu, C; Nakano, V; Senhorinho, GN; Song, Y | 1 |
| Alihodžić, S; Bencetić Mihaljević, V; Bosnar, M; Bošnjak, B; Brajša, K; Culić, O; Eraković Haber, V; Glojnarić, I; Hrvačić, B; Jelić, D; Kapić, S; Koštrun, S; Kragol, G; Marušić Ištuk, Z; Padovan, J; Spaventi, R; Tavčar, B; Verbanac, D; Vujasinović, I | 1 |
| Blondeau, JM; Drlica, K; Metzler, K | 1 |
| Hernández-Díaz, S; Lin, KJ; Louik, C; Mitchell, AA; Yau, WP | 1 |
| Adegbola, RA; Antonio, M; Berg, DE; Corrah, T; Galano, JJ; Sancho, J; Secka, O; Tapgun, M; Thomas, JE; Thomas, V; Walton, R | 1 |
| Becka, M; Kubitza, D; Mueck, W | 1 |
| Decramer, M; Laekeman, G; Simoens, S | 1 |
| An, K; Cushman, M; Li, XL; Liang, JH; Lv, W; Wang, H; Xu, YC | 1 |
| Cha, HH; Choi, SJ; Kim, JH; Kim, JS; Kwak, HM; Lee, JH; Oh, SY; Roh, CR; Shin, MY | 1 |
| Akiyoshi, T; Guengerich, FP; Ito, M; Miyazaki, M; Murase, S; Nakamura, K; Ohtani, H; Yamamoto, K | 1 |
| Abe, A; Che, XF; Gotoh, A; Inazu, M; Kawaguchi, T; Komatsu, S; Miyazawa, K; Moriya, S; Tomoda, A | 1 |
| Bailey, DG; Fleet, J; Gandhi, S; Garg, AX; Gomes, T; Hwang, YJ; Juurlink, DN; Mamdani, M; Patel, AM; Shariff, S | 1 |
| Donaldson, GC; James, GD; Nazareth, I; Petersen, I; Wedzicha, JA | 1 |
| Berghaus, LJ; Giguère, S; Guldbech, K | 1 |
| Alffenaar, JW; Buchard, A; Dalbøge, CS; Dalhoff, K; Duno, M; Høiby, N; Jensen, AG; Johansen, HK; Jürgens, G; Nielsen, XC; Pressler, T; Uges, DR | 1 |
| Herath, SC; Poole, P | 1 |
| Akagawa, KS; Hirose, T; Kobayashi, K; Nagao, T; Nakayama, T; Ōmura, S; Oshima, M; Sugamata, R; Sugawara, A; Sunazuka, T; Suzuki, K; Yamamoto, K | 1 |
| Nilsson, MF; Webster, WS | 1 |
| Alechaga, E; Boleda, MR; Galceran, MT; Moyano, E; Ventura, F | 1 |
| Ihi, T; Ishii, H; Kadota, J; Komiya, K; Kudoh, S; Kurashima, A; Matsumoto, N; Mizunoe, S; Nagai, H; Ohta, K; Takahashi, O | 1 |
| Das, T; Foroutan, P; Gatenby, RA; Gillies, RJ; Kam, Y; Martinez, G; Minton, S; Ruiz, E; Tian, H | 1 |
| Hofmann, T; Scheuch, G; Siekmeier, R | 1 |
| Burkin, M; Galvidis, I; Lapa, G | 1 |
| Del Mar, CB; Eriksson, L; Farley, R; Spurling, GK | 1 |
| Blix, HS; Christensen, A; Hjellvik, V; Skaare, D; Steinbakk, M; Vestrheim, DF | 1 |
| Chen, X; Li, X; Luo, F; Pan, C; Tan, F; Zheng, X; Zhou, Z | 1 |
| Maruyama, F; Masuda, M; Nonaka, L; Suzuki, S | 1 |
| Kouzaki, H; Ogawa, T; Omura, S; Shimizu, S; Shimizu, T; Sunazuka, T; Tojima, I | 1 |
| Kasai, A; Nishiyama, H; Ogihara, S; Saito, R; Tanimichi, Y; Yamada, K | 1 |
| Cardona, AF; Reveiz, L | 1 |
| Eybagi, S; Kazerouni, NP; Naserzadeh, P; Pourahmad, J; Salimi, A; Seydi, E | 1 |
| Fujiwara, R; Itoh, T; Sakamoto, M; Takagi, M | 1 |
| Shimizu, T; Suzaki, H | 1 |
| Bérard, A; Nordeng, H; Sheehy, O; Zhao, JP | 1 |
| Che, XF; Handa, H; Hiramoto, M; Itoi, T; Kazama, H; Kokuba, H; Miyazawa, K; Moriya, S; Mukai, S; Ōmura, S; Sakamoto, S; Sugawara, A; Sunazuka, T; Yokoyama, T | 1 |
| Dixon, SN; Garg, AX; Hackam, DG; Jandoc, R; McArthur, E; Nash, DM; Trac, MH | 1 |
| Li, C; Li, X; Liu, G; Wang, M; Wang, Z; Zhou, L | 1 |
| Renaud, J; Sabourin, L; Sumarah, M; Topp, E | 1 |
| Cai, C; Chen, J; Cheng, C; Cheng, G; Hu, X; Li, M; Liu, C | 1 |
| Chang, KH; Choi, SJ; Kim, HJ; Kim, JH; Kim, JS; Lee, J; Oh, SY; Roh, CR; Yu, HJ | 1 |
| Bannister, CA; Berni, E; Butler, CC; Currie, CJ; de Voogd, H; Halcox, JP; Jenkins-Jones, S; Jones, B; Ouwens, M | 1 |
| Altman, RB; Fohner, AE; Klein, TE; Sparreboom, A | 1 |
| Giguère, S | 1 |
| Attaran, B; Falsafi, T; Ghorbanmehr, N | 1 |
| Gomes, T; Huang, A; Juurlink, DN; Macdonald, EM; Mamdani, MM; Quinn, KL | 1 |
| Adir, Y; Lavon, O; Schneer, S; Shteinberg, M | 1 |
| Bester, K; Casas, ME; Feng, L; Møller, HB; Ottosen, LDM | 1 |
| Jia, L; Ma, S; Qiang, S; Qin, Y; Shen, Y; Yan, M | 1 |
| Gergova, RT; Mitov, IG; Muhtarova, AA | 1 |
| Ghosh, M; Graham, DJ; Izem, R; Kang, EM; Lee, JY; Major, JM; Mosholder, AD; Zhou, EH | 1 |
| Berghaus, LJ; Giguère, S; Willingham-Lane, JM | 1 |
| Fabiánová, K; Jakubů, V; Urbášková, P; Zavadilová, J | 1 |
| Hosono, Y; Kagawa, H; Kitada, S; Miki, K; Miki, M; Mori, M; Oshitani, Y; Yano, Y; Yokota, S; Yoshimura, K | 1 |
| Chalmers, JD; Crossingham, I; Evans, DJ; Felix, LM; Kelly, C; Milan, SJ; Relph, N; Spencer, S | 1 |
| Gorelik, E; Masarwa, R; Matok, I; Muszkat, M; Perlman, A; Rotshild, V | 1 |
| Alyabieva, NM; Katosova, LK; Khokhlova, TA; Lazareva, AV; Ponomarenko, OA | 1 |
| Aktan, B; Ersoy, B; Kilic, K; Sakat, MS; Sipal, S | 1 |
| Aderemi, AO; Alves, LM; Hunter, C; Lemos, MFL; Novais, SC; Pahl, O | 1 |
| Barr, BS; Carter, CN; Cohen, ND; Elam, J; Erol, E; Giguère, S; Huber, L; Locke, SJ; Phillips, ED; Slovis, NM; Smith, JL | 1 |
| Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
| Ishida, M; Matsune, S; Okubo, K; Ōmura, S; Sekine, K; Sunazuka, T; Takahara, E; Wakayama, N; Yamaguchi, S; Yoshioka, Y | 1 |
| Kawashima, H; Nakajima, J; Sunohara, D | 1 |
| Aljabri, A; Almehmadi, M; Alqahtani, N; Alraddadi, B; Aseeri, MA; Assabban, Z; Bahobail, F; Botaish, A; Eljaaly, K; Hashim, A; Thabit, AK; Torres, A | 1 |
| Bianco, G; Bufo, SA; Caniani, D; Coviello, D; Cristina Lafiosca, M; Mancini, IM; Masi, S; Pascale, R; Scrano, L | 1 |
| Cahn, AP; Georgiou, A; Harrell, AW; Hessel, EM; Marotti, M; Patel, A; Riddell, K; Taskar, KS; Taylor, M; Tracey, H; Wilson, R | 1 |
| Carter, C; Cruz Penn, MJ; Erol, E; Fortner, J; Locke, S; Saied, A; Smith, J | 1 |
| Katsukawa, C; Kawahara, R; Kawasaki, Y; Kawatsu, K; Yamaguchi, T | 1 |
| Boroumand, B; Hajimirzaei, N; Judi-Chelan, R; Khalili, NP; Pourhosseini, A; Safari, F; Tavakoli, F | 1 |
| Ashcroft, DM; Brown, B; Li, Y; Palin, V; van Staa, TP; Welfare, W | 1 |
| Demarque, DP; Heinrich, S; Merten, C; Schulz, F | 1 |
| Pejčić, AV | 2 |
| Akeda, Y; Arakawa, Y; Miyamoto, K; Onda, M; Shoji, M; Terada, K; Tomono, K; Tsuchiya, T; Yamabe, K | 1 |
| Domon, H; Hirayama, S; Hiyoshi, T; Isono, T; Maekawa, T; Sasagawa, K; Tamura, H; Terao, Y; Yanagihara, K | 1 |
| Hussain, Z; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L | 1 |
| Alharbi, L; Alkhamisi, R; Alradadi, R; Ashy, N; Eljaaly, K | 1 |
| Gomez-Lumbreras, A; Malone, DC; Tan, MS; Villa-Zapata, L | 1 |
| Catherine Stanton, I; Hayes, A; Hugo Gaze, W; Kaye Murray, A; May Murray, L; Snape, J; Zhang, L | 1 |
| Cummins, E; Monahan, C; Morris, D; Nag, R | 1 |
| Hussain, Z; Li, L; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L; Yang, Y | 1 |
| Jiang, B; Jing, XL; Li, GA; Li, SS; Ling, WC; Sui, SS; Sun, CY; Wang, YL | 1 |
67 review(s) available for erythromycin and clarithromycin
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clarithromycin and azithromycin: new macrolide antibiotics.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Drug Interactions; Drug Labeling; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria | 1992 |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Drug Interactions; Erythromycin; Humans; Macrolides; Roxithromycin | 1992 |
The new macrolide antibiotics. Azithromycin and clarithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Protocols; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Humans; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious; Therapeutic Equivalency | 1992 |
Azithromycin and clarithromycin: overview and comparison with erythromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious | 1992 |
New macrolide antibiotics: clarithromycin and azithromycin.
Topics: Azithromycin; Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections; Skin Diseases, Infectious | 1992 |
The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
Topics: Azithromycin; Clarithromycin; Drug Interactions; Erythromycin; Humans; Respiratory Tract Infections | 1992 |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
Topics: Aged; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant | 1992 |
Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Interactions; Erythromycin; Humans; Macrophages; Mycobacterium avium-intracellulare Infection; Respiratory Tract Infections; Skin Diseases, Infectious | 1992 |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Macrophages; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1992 |
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview.
Topics: Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections; Skin Diseases, Infectious | 1992 |
Clarithro- and azithromycin--better erythromycins?
Topics: Adult; Azithromycin; Clarithromycin; Erythromycin; Humans | 1991 |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
Topics: Administration, Oral; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Incidence; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1991 |
The pharmacokinetics of clarithromycin and its 14-OH metabolite.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Tissue Distribution | 1991 |
The tolerance and toxicity of clarithromycin.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Clarithromycin; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Erythromycin; Female; Gastrointestinal Diseases; Humans; Incidence; Male; Middle Aged | 1991 |
Treatment of Legionnaires' disease. Current recommendations.
Topics: Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Tolerance; Erythromycin; Humans; Infusions, Parenteral; Legionnaires' Disease; Rifampin | 1993 |
New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteremia; Clarithromycin; Drug Synergism; Erythromycin; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mycobacterium Infections, Nontuberculous; Randomized Controlled Trials as Topic | 1994 |
[Recent progress on diagnosis and therapy of diffuse panbronchiolitis].
Topics: Adult; Aged; Bacterial Infections; Bronchiolitis; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged | 1993 |
Azithromycin and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests | 1993 |
[Azithromycin: critical points].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; In Vitro Techniques; Macrolides | 1995 |
Dirithromycin: a new macrolide.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Clarithromycin; Drug Interactions; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Macrolides; Respiratory Tract Infections | 1996 |
History of macrolide use in pediatrics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Interactions; Erythromycin; Haemophilus Infections; Haemophilus influenzae; History, 20th Century; Humans; Infant; Infant, Newborn; Microscopy, Electron; Phagocytes; Phagocytosis | 1997 |
Microbiologic activity of the newer macrolide antibiotics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Ear, Middle; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae | 1997 |
Macrolides in the management of streptococcal pharyngitis/tonsillitis.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Erythromycin; Humans; Penicillins; Pharyngitis; Streptococcal Infections; Tonsillitis | 1997 |
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Hypersensitivity; Drug Interactions; Erythromycin; Humans; Liver Function Tests | 1999 |
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen.
Topics: Anti-Bacterial Agents; Area Under Curve; Biological Availability; Clarithromycin; Drug Administration Schedule; Erythromycin; Humans; Microbial Sensitivity Tests | 1999 |
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Interactions; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic | 1999 |
The macrolides: erythromycin, clarithromycin, and azithromycin.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests | 1999 |
[Clinical application of the new action of macrolide preparations to respiratory diseases].
Topics: Anti-Bacterial Agents; Bacterial Infections; Bronchiectasis; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Immunologic Factors; Lung Neoplasms | 1999 |
Dental therapeutic indications for the newer long-acting macrolide antibiotics.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Dental Care for Chronically Ill; Drug Costs; Endocarditis, Bacterial; Erythromycin; Focal Infection, Dental; Humans; Liver; Macrolides; Prodrugs; Tissue Distribution | 1999 |
Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Erythromycin; Humans; Macrolides; Mixed Function Oxygenases; Substrate Specificity | 2000 |
Therapy with macrolides in patients with cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Humans; Inflammation; Molecular Structure; Pseudomonas aeruginosa | 2002 |
Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Humans; Miocamycin | 2002 |
The evolution and role of macrolides in infectious diseases.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Biological Availability; Child; Clarithromycin; Communicable Diseases; Drug Resistance, Bacterial; Erythromycin; Half-Life; Humans; Metabolic Clearance Rate | 2002 |
[Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: New pharmacological action of macrolides].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; History, 20th Century; Humans; Japan; Lung Neoplasms; Respiratory Tract Infections | 2002 |
[Macrolide].
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Biofilms; Clarithromycin; Erythromycin; Humans; Lipid Peroxidation; Lymphocytes; Macrophages; Neutrophils; Peristalsis; Respiratory Mucosa; Structure-Activity Relationship | 2003 |
Macrolide antibiotic therapy in patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Humans; Randomized Controlled Trials as Topic | 2003 |
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Chronic Disease; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Inflammation; Macrolides; Respiratory Tract Infections | 2005 |
Antibiotics for whooping cough (pertussis).
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Clarithromycin; Contact Tracing; Erythromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Humans; Infant; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2005 |
[Pertussis chemoprophylaxis: a sterile effort?].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Drug Administration Schedule; Erythromycin; Humans; Risk Factors; Severity of Illness Index; Whooping Cough | 2006 |
[Antibiotics treatment of whooping cough].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Humans; Infant; Meta-Analysis as Topic; Patient Compliance; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2006 |
[Diagnosis and therapy of Rhodococcus equi infection in the horse].
Topics: Actinomycetales Infections; Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Treatment Outcome | 2006 |
Biofilms in ear, nose, and throat infections: how important are they?
Topics: Anti-Bacterial Agents; Bacterial Infections; Biofilms; Chronic Disease; Clarithromycin; Cochlear Implants; Combined Modality Therapy; Erythromycin; Foreign Bodies; Humans; Middle Ear Ventilation; Otitis Media with Effusion; Pharynx; Phenotype; Prosthesis-Related Infections; Sinusitis | 2007 |
Antibiotics for whooping cough (pertussis).
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Clarithromycin; Contact Tracing; Erythromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Humans; Infant; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2007 |
Macrolide therapy of chronic rhinosinusitis.
Topics: Anti-Bacterial Agents; Biofilms; Chemotaxis, Leukocyte; Chronic Disease; Clarithromycin; Erythromycin; Humans; Macrolides; Rhinitis; Roxithromycin; Sinusitis | 2007 |
Long-acting erythromycins: assessing their role in treating outpatient odontogenic infections.
Topics: Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Delayed-Action Preparations; Erythromycin; Humans; Tooth Diseases | 2009 |
Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics.
Topics: Anti-Bacterial Agents; Azithromycin; Chemistry, Pharmaceutical; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides | 2010 |
Antibiotics for bronchiolitis in children.
Topics: Ampicillin; Anti-Bacterial Agents; Bronchiolitis; Clarithromycin; Erythromycin; Humans; Infant; Length of Stay; Randomized Controlled Trials as Topic | 2011 |
Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics.
Topics: Adult; Africa South of the Sahara; Anti-Bacterial Agents; Asia; Azithromycin; Child; Clarithromycin; Community-Acquired Infections; Confounding Factors, Epidemiologic; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Klebsiella; Macrolides; Microbial Sensitivity Tests; Neisseria meningitidis; Salmonella enterica; Streptococcus agalactiae; Streptococcus pyogenes | 2011 |
Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Belgium; Clarithromycin; Drug Costs; Erythromycin; Health Care Costs; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2013 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Disease Progression; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic | 2013 |
Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Ketolides; Lung; Macrolides; Pulmonary Disease, Chronic Obstructive; Rats | 2015 |
Antibiotics for bronchiolitis in children under two years of age.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Clarithromycin; Erythromycin; Humans; Infant; Length of Stay; Randomized Controlled Trials as Topic | 2014 |
Antibiotics for acute laryngitis in adults.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Clarithromycin; Depsipeptides; Erythromycin; Fusarium; Humans; Laryngitis; Penicillin V; Randomized Controlled Trials as Topic | 2015 |
Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; Haemophilus Infections; History, 20th Century; History, 21st Century; Humans; Japan; Macrolides; Nasal Polyps; Rhinitis; Sinusitis | 2016 |
[Effects of mucolytic agents and macrolides in the treatment of COPD].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiviral Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Erythromycin; Expectorants; Goblet Cells; Humans; Hyperplasia; Macrolides; Mucins; Mucociliary Clearance; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Treatment Outcome | 2016 |
Treatment of Infections Caused by Rhodococcus equi.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin | 2017 |
[LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Lung Diseases; Macrolides | 2016 |
Antimicrobial Resistance in
Topics: Animal Diseases; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Horses; Lincosamides; Macrolides; Microbial Sensitivity Tests; Rhodococcus equi; Rifampin; Streptogramin B | 2017 |
Macrolide antibiotics for bronchiectasis.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Child, Preschool; Clarithromycin; Erythromycin; Humans; Macrolides; Randomized Controlled Trials as Topic; Roxithromycin | 2018 |
Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Erythromycin; Macrolides; Myocardial Infarction; Network Meta-Analysis; Risk Factors | 2018 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Humans; Male; Pneumonia, Bacterial | 2020 |
Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Humans; Ketolides; Macrolides; Roxithromycin; Stevens-Johnson Syndrome | 2021 |
Delirium associated with the use of macrolide antibiotics: a review.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Delirium; Erythromycin; Humans | 2022 |
Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Pneumonia; Randomized Controlled Trials as Topic | 2022 |
62 trial(s) available for erythromycin and clarithromycin
| Article | Year |
|---|---|
Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Macrolides; Male; Middle Aged; Treatment Outcome; Young Adult | 2009 |
New antibiotics look good against M. avium.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Erythromycin; Humans; Mycobacterium avium-intracellulare Infection | 1992 |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.
Topics: Aged; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant | 1992 |
Absolute bioavailability of clarithromycin after oral administration in humans.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Clarithromycin; Erythromycin; Humans; Injections, Intravenous; Male | 1992 |
Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial.
Topics: Absorption; Administration, Oral; Adult; Biological Availability; Chromatography, High Pressure Liquid; Clarithromycin; Erythromycin; Fasting; Food; Humans; Male | 1992 |
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Ampicillin; Bacterial Infections; Bronchitis; Chi-Square Distribution; Chronic Disease; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome | 1992 |
Effect of viral respiratory tract infection on outcome of acute otitis media.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefpodoxime; Ceftizoxime; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Treatment Outcome; Virus Diseases | 1992 |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
Topics: Administration, Oral; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Incidence; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1991 |
A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Ampicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged | 1991 |
Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Remission Induction; Roxithromycin | 1991 |
A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia | 1991 |
Efficacy of clarithromycin against Mycoplasma pneumoniae.
Topics: Adolescent; Adult; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Sputum | 1991 |
The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clarithromycin; Erythromycin; Humans; Lung; Middle Aged; Nasal Mucosa; Palatine Tonsil; Roxithromycin | 1991 |
Clarithromycin versus penicillin in the treatment of streptococcal pharyngitis.
Topics: Adolescent; Adult; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Remission Induction; Streptococcal Infections; Streptococcus pyogenes | 1991 |
A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis.
Topics: Adolescent; Adult; Ambulatory Care; Child; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1991 |
The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Ambulatory Care; Amoxicillin; Clarithromycin; Erythromycin; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Remission Induction; Single-Blind Method | 1991 |
Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Remission Induction; Sputum | 1991 |
Safety and efficacy of Clarithromycin in the treatment of acute mild to moderate respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1991 |
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1991 |
The safety and efficacy of clarithromycin in patients with Legionella pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clarithromycin; Erythromycin; Female; Humans; Legionnaires' Disease; Male; Middle Aged | 1991 |
Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitis.
Topics: Adolescent; Adult; Child; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1991 |
Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out-patients with acute maxillary sinusitis.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Multicenter Studies as Topic; Outpatients | 1990 |
Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Gastrointestinal Diseases; Humans; Male; Outpatients; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes | 1990 |
[A clinical evaluation of clarithromycin in the treatment of pediatric infections].
Topics: Age Factors; Bacteria; Bronchitis; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enteritis; Erythromycin; Female; Humans; Male; Multicenter Studies as Topic; Tonsillitis | 1989 |
[Bacteriological, pharmacokinetic and clinical studies on clarithromycin in the pediatric field. Pediatric Study Group of Clarithromycin].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male; Multicenter Studies as Topic | 1989 |
[Clinical evaluation of clarithromycin in treatment of acute dental infections. Comparative double-blind study using josamycin as the control].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Clarithromycin; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Female; Humans; Leucomycins; Male; Middle Aged; Multicenter Studies as Topic; Tooth Diseases | 1989 |
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.
Topics: Adult; Clarithromycin; Erythromycin; Female; Humans; Lung; Male; Prospective Studies; Smoking | 1995 |
A randomized comparative study on the safety and efficacy of clarithromycin and erythromycin in treating community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial | 1995 |
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.
Topics: Child; Child, Preschool; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 1994 |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group.
Topics: Cefadroxil; Clarithromycin; Double-Blind Method; Erythromycin; Humans; Single-Blind Method; Skin Diseases, Bacterial | 1993 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Administration Schedule; Erythromycin; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1993 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Bronchitis; Clarithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections | 1993 |
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Canada; Child; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Pneumonia; Sweden; Tablets | 1993 |
A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Female; Humans; Macrolides; Male; Middle Aged; Patient Compliance; Single-Blind Method | 1995 |
Antibiotic treatment in mice infected with Japanese Borrelia garinii: efficacy of ceftriaxone for eradicating the infection induced by Ixodes persulcatus tick bites.
Topics: Animals; Anti-Bacterial Agents; Arthropod Vectors; Ceftriaxone; Cephalosporins; Clarithromycin; Ear, External; Erythromycin; Female; Heart; Ixodes; Japan; Lyme Disease; Mice; Mice, Inbred C3H; Recurrence; Urinary Bladder | 1997 |
[Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Mice; Middle Aged | 1997 |
Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Culture Media; Double-Blind Method; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Reference Standards; Respiratory Tract Infections | 1997 |
Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
Topics: Anti-Anxiety Agents; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Cross-Over Studies; Drug Interactions; Erythromycin; Female; Humans; Male; Midazolam | 1997 |
[Study of efficacy of macrolide therapy applied to Kartagener's syndrome].
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Humans; Kartagener Syndrome; Male | 1998 |
Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
Topics: Administration, Oral; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Erythromycin; Humans; Hypnotics and Sedatives; In Vitro Techniques; Microsomes, Liver; Oxidoreductases, N-Demethylating; Time Factors; Triazolam; Troleandomycin | 1998 |
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Area Under Curve; Biotransformation; Breath Tests; Carbamates; Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Erythromycin; Furans; Half-Life; Humans; Liver Function Tests; Male; Mixed Function Oxygenases; Sulfonamides | 2000 |
A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Humans; Male; Pneumonia; Radiography, Thoracic; Roxithromycin | 2000 |
An open trial of oral macrolide treatment for psoriasis vulgaris.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Ointments; Pruritus; Psoriasis; Roxithromycin; Severity of Illness Index; Treatment Outcome | 2000 |
[Therapeutic effects of macrolides on patients with psoriasis vulgaris, pigmentary prurigo, or eosinophilic pustule folliculitis].
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Folliculitis; Humans; Male; Middle Aged; Prurigo; Psoriasis; Roxithromycin; Treatment Outcome | 2001 |
[Therapeutic effects of macrolides on patients with palmoplantar pustulosis].
Topics: Adult; Aged; Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Cytokines; Erythromycin; Female; Humans; Interleukin-8; Keratinocytes; Male; Middle Aged; Psoriasis; Treatment Outcome | 2001 |
Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial.
Topics: Anti-Bacterial Agents; Bordetella pertussis; Child; Child, Preschool; Clarithromycin; Erythromycin; Female; Humans; Male; Prospective Studies; Single-Blind Method; Treatment Outcome; Whooping Cough | 2001 |
Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.
Topics: Adult; Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Cefaclor; Chlorides; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Membrane Potentials; Middle Aged; Rabbits; Sputum; Trachea | 2002 |
The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Cardiotonic Agents; Clarithromycin; Digoxin; Drug Interactions; Erythromycin; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate | 2002 |
[Continuous low-dosage macrolide therapy in children with bronchial asthma].
Topics: Anti-Bacterial Agents; Asthma; Child; Child, Preschool; Clarithromycin; Erythromycin; Female; Humans; Infant; Male; Time Factors; Treatment Outcome | 2001 |
[Evidence-based macrolide therapy for children with serous otitis media].
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Erythromycin; Evidence-Based Medicine; Humans; Otitis Media with Effusion; Time Factors; Treatment Outcome | 2001 |
Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: a multicenter, randomized, double-blind, parallel-group study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Macrolides; Male; Middle Aged; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2003 |
Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral st
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Erythromycin; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia | 2003 |
[Beneficial effects of macrolide antibiotics on children with influenza].
Topics: Adolescent; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Influenza, Human; Male; Pharynx; Pneumonia, Bacterial; Treatment Outcome | 2003 |
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies; Random Allocation; Treatment Outcome | 2007 |
Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Ofloxacin; Pneumonia; Treatment Outcome | 2007 |
An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Clarithromycin; Community-Acquired Infections; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Mycoplasma Infections; Pneumonia; Treatment Outcome | 2008 |
A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Erythrasma; Erythromycin; Female; Fusidic Acid; Humans; Male; Middle Aged; Skin Cream; Skin Diseases, Bacterial; Treatment Outcome; Young Adult | 2013 |
Macrolide antibiotics and survival in patients with acute lung injury.
Topics: Acute Lung Injury; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; APACHE; Azithromycin; Clarithromycin; Combined Modality Therapy; Drug Administration Schedule; Erythromycin; Female; Hospital Mortality; Humans; Length of Stay; Macrolides; Male; Middle Aged; Pentoxifylline; Respiration, Artificial; Survival Rate; Tidal Volume | 2012 |
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant | 2012 |
Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects.
Topics: Adolescent; Adult; Anticoagulants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Erythromycin; Humans; Ketoconazole; Metabolic Clearance Rate; Midazolam; Middle Aged; Morpholines; Rivaroxaban; Substrate Specificity; Thiophenes; Young Adult | 2013 |
The efficacy of cefazolin plus macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and placental inflammation for women with preterm premature rupture of membranes.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Chorioamnionitis; Clarithromycin; Echoencephalography; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant; Infant, Newborn; Nervous System Diseases; Pregnancy | 2013 |
Drug Interactions for Low-Dose Inhaled Nemiralisib: A Case Study Integrating Modeling, In Vitro, and Clinical Investigations.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Area Under Curve; Clarithromycin; Computer Simulation; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Healthy Volunteers; Humans; Indazoles; Indoles; Itraconazole; Male; Microsomes, Liver; Midazolam; Middle Aged; Models, Biological; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Prospective Studies; Retrospective Studies; Young Adult | 2020 |
544 other study(ies) available for erythromycin and clarithromycin
| Article | Year |
|---|---|
Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocida.
Topics: Animals; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Macrolides; Mice; Microbial Sensitivity Tests; Molecular Structure; Pasteurella Infections; Pasteurella multocida; Structure-Activity Relationship | 1997 |
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Clarithromycin; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Mice; Molecular Conformation; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin | 1998 |
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Lincosamides; Macrolides; Mice; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin | 1998 |
Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Crystallography, X-Ray; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Ketolides; Macrolides; Male; Mice; Models, Molecular; Molecular Conformation; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus; Streptococcus pneumoniae | 1998 |
In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones.
Topics: Benzoxazoles; Helicobacter pylori; Inhibitory Concentration 50; Ketones | 1999 |
Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivatives.
Topics: Anti-Infective Agents; Erythromycin; Microbial Sensitivity Tests; Structure-Activity Relationship | 2000 |
Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Membrane; Cell Survival; Cyclosporine; Drug Resistance, Neoplasm; Immunosuppressive Agents; Leukemia P388; Macrolides; Mice; Neoplasm Transplantation; Tumor Cells, Cultured; Verapamil; Vinblastine | 2000 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives): a novel class of macrolide antibiotics.
Topics: Animals; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Structure-Activity Relationship | 2001 |
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cell-Free System; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Mice; Models, Molecular; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Respiratory Tract Infections; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Transcription, Genetic | 2001 |
Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Drug Resistance, Multiple, Bacterial; Erythromycin; Haemophilus influenzae; Macrolides; Mice; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Streptococcal Infections; Streptococcus pneumoniae; Structure-Activity Relationship | 2003 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Drug Interactions; Erythromycin; Humans; Kinetics; Liver; Oocytes; Organic Anion Transporters, Sodium-Independent; Phosphodiesterase Inhibitors; Protein Binding; RNA, Complementary; Theophylline; Xenopus laevis | 2005 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Synthesis and biological investigation of new 4''-malonyl tethered derivatives of erythromycin and clarithromycin.
Topics: Cell-Free System; Clarithromycin; Erythromycin; Protein Synthesis Inhibitors; Ribosomes; RNA, Ribosomal, 23S | 2006 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Bacterial; Genotype; Humans; Ketolides; Methyltransferases; Microbial Sensitivity Tests; Mutation; Phenotype; Pneumococcal Infections; Ribosomal Proteins; Streptococcus pneumoniae | 2007 |
Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Disease Models, Animal; Drug Resistance, Bacterial; Lung; Macrolides; Male; Matrix Metalloproteinase 7; Mice; Mice, Inbred CBA; Pneumonia, Pneumococcal; Roxithromycin; Streptolysins | 2007 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Campylobacter jejuni; Clarithromycin; Culture Media; Dipeptides; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Macrolides; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Tetracycline Resistance | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; RNA, Ribosomal, 23S | 2008 |
Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation.
Topics: 5' Untranslated Regions; Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Ketolides; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; RNA, Ribosomal; Sequence Deletion; Streptococcus pneumoniae | 2008 |
Induction of erm(C) expression by noninducing antibiotics.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enzyme Induction; Escherichia coli; Gene Expression Regulation, Bacterial; Ketolides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Conformation; Protein Sorting Signals; Ribosomes; RNA, Messenger | 2008 |
Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes.
Topics: Cells, Cultured; Clarithromycin; Epidermal Cells; Epidermis; Erythromycin; Humans; Interleukin-1beta; Interleukin-8; Keratinocytes; Macrolides; Receptor, PAR-2; Roxithromycin | 2008 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Female; Genetic Heterogeneity; Humans; Infant, Newborn; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Phylogeny; Sequence Analysis, DNA; Streptococcus agalactiae | 2008 |
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Macrolides; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Sequence Homology, Amino Acid | 2009 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.
Topics: Anti-Infective Agents; Borrelia burgdorferi; Borrelia burgdorferi Group; Guidelines as Topic; Humans; Lyme Disease; Microbial Sensitivity Tests; Time Factors | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.
Topics: Amino Acid Sequence; Clarithromycin; Drug Resistance, Bacterial; Humans; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium chelonae; Nontuberculous Mycobacteria; Polymerase Chain Reaction; RNA | 2009 |
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Global Health; Humans; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Population Surveillance; Respiratory Tract Infections; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus pyogenes | 2009 |
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Erythromycin; Humans; Infant, Newborn; Infant, Premature, Diseases; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Species Specificity; Tetracycline; Ureaplasma; Ureaplasma Infections | 2009 |
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
Topics: Adolescent; Adult; Aged; Bacterial Capsules; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Polymerase Chain Reaction; Streptococcus agalactiae | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Nucleotide selectivity of antibiotic kinases.
Topics: Anti-Bacterial Agents; Bacteria; Binding, Competitive; Drug Resistance, Bacterial; Guanosine Triphosphate; Kanamycin Kinase; Models, Chemical; Nucleotides; Phosphotransferases (Alcohol Group Acceptor); Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Substrate Specificity | 2010 |
Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Base Sequence; Biofilms; DNA Primers; Dose-Response Relationship, Drug; Erythromycin; Gene Expression; Genes, Bacterial; Humans; In Vitro Techniques; Macrolides; Microscopy, Electron, Scanning; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus epidermidis | 2010 |
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Synthesis and antibacterial activity of novel 4''-O-arylalkylcarbamoyl and 4''-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives.
Topics: Anti-Bacterial Agents; Clarithromycin; Genes, Bacterial; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Drug Discovery; Microbial Sensitivity Tests | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Topics: Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Clarithromycin; Doxycycline; Erythromycin; Genotype; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2010 |
Synthesis and antibacterial activity of C-12 pyrazolinyl spiro ketolides.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Haemophilus influenzae; Ketolides; Microbial Sensitivity Tests; Molecular Conformation; Pyrazoles; Spiro Compounds; Staphylococcus; Stereoisomerism; Structure-Activity Relationship | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Design; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Molecular Conformation; Staphylococcus aureus; Stereoisomerism; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2011 |
Chemistry and biology of macrolide antiparasitic agents.
Topics: Anti-Bacterial Agents; Antiparasitic Agents; Cells, Cultured; Humans; Macrolides; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Toxoplasma | 2011 |
Synthesis and antibacterial activity of novel 4″-O-benzimidazolyl clarithromycin derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Gene Expression; Hydrazines; Membrane Proteins; Methyltransferases; Staphylococcus aureus; Streptococcus pneumoniae; Structure-Activity Relationship | 2011 |
Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Design; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Models, Chemical; Nitrogen; Respiratory Tract Infections; Streptococcus pneumoniae | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes.
Topics: Animals; Hepatocytes; Male; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Ketolides; Microbial Sensitivity Tests; Molecular Conformation; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus Phages; Streptococcus pneumoniae; Structure-Activity Relationship | 2012 |
Synthesis and antibacterial evaluation of novel 11,4″-disubstituted azithromycin analogs with greatly improved activity against erythromycin-resistant bacteria.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Bacterial; Erythromycin; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
Synthesis of novel isothiazolopyridines and their in vitro evaluation against Mycobacterium and Propionibacterium acnes.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Crystallography, X-Ray; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium; Mycobacterium tuberculosis; Propionibacterium acnes; Pyridines; Structure-Activity Relationship; Thiazoles; Vero Cells | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones | 2017 |
Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility.
Topics: 1-Octanol; Cell Membrane Permeability; Cyclosporins; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Peptides; Peptides, Cyclic; Pharmaceutical Preparations; Small Molecule Libraries; Solubility; Structure-Activity Relationship; Water | 2018 |
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Macrolides | 2020 |
Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Benzamides; Binding Sites; Cell Survival; Cytoskeletal Proteins; Drug Design; Drug Resistance, Bacterial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Isoxazoles; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Structure-Activity Relationship | 2020 |
Opportunities and Limitations for Assigning Relative Configurations of Antibacterial Bislactones using GIAO NMR Shift Calculations.
Topics: Anti-Bacterial Agents; Biological Products; Fungi; Lactones; Magnetic Resonance Spectroscopy; Molecular Structure; Phylogeny; Stereoisomerism | 2021 |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin | 1992 |
New macrolide antibiotics: azithromycin and clarithromycin.
Topics: Animals; Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans | 1992 |
Studies show new macrolide antibiotics to be superior to some older agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Quinolones | 1992 |
Two macrolide antimicrobials approved for marketing.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans; United States; United States Food and Drug Administration | 1992 |
Clarithromycin and azithromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Clinical Trials as Topic; Erythromycin; Humans; Microbial Sensitivity Tests | 1992 |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.
Topics: Azithromycin; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Roxithromycin | 1992 |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Ofloxacin | 1992 |
Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
Topics: Anti-Bacterial Agents; Azithromycin; Chediak-Higashi Syndrome; Child; Clarithromycin; Colony Count, Microbial; Erythromycin; Female; Humans; Neutrophils; Phagocytosis; Roxithromycin; Staphylococcus aureus | 1992 |
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Topics: Azithromycin; Bacteria; Cefotaxime; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Miocamycin; Roxithromycin; Virginiamycin | 1992 |
Activity of azithromycin against Mycobacterium avium infection in beige mice.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Culture Media; Drug Therapy, Combination; Erythromycin; Female; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Tuberculosis | 1992 |
Clarithromycin and omeprazole for Helicobacter pylori.
Topics: Clarithromycin; Erythromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1992 |
Protective efficacy of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae in a murine septicaemia model.
Topics: Animals; Bacteremia; Clarithromycin; Disease Models, Animal; Drug Synergism; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Mice; Mice, Inbred BALB C | 1992 |
Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.
Topics: Abscess; Administration, Oral; Adrenal Cortex Hormones; Anti-Bacterial Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Catheters, Indwelling; Cellulitis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Organ Transplantation; Osteomyelitis; Risk Factors; Skin Diseases, Infectious; United States | 1992 |
New macrolide antibiotics.
Topics: Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia | 1992 |
Individual efficacy of clarithromycin (A-56268) and its major human metabolite 14-hydroxy clarithromycin (A-62671) in experimental pneumococcal pneumonia in the mouse.
Topics: Animals; Clarithromycin; Erythromycin; Female; Lung; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1992 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals.
Topics: Acquired Immunodeficiency Syndrome; Cells, Cultured; Clarithromycin; Drug Therapy, Combination; Erythromycin; Humans; Macrophages, Alveolar; Mycobacterium avium Complex | 1992 |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Bacteremia; Cause of Death; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Pilot Projects | 1992 |
Clarithromycin-induced thrombocytopenia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Erythromycin; Humans; Male; Mycobacterium avium-intracellulare Infection; Thrombocytopenia | 1992 |
[Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases--the fourth report].
Topics: Adult; Aged; Animals; Chronic Disease; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Erythromycin; Female; Humans; Mice; Middle Aged; Respiratory Tract Infections; Time Factors | 1992 |
Effects of macrolides on ultrastructure of Staphylococcus aureus during postantibiotic phase.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Josamycin; Microscopy, Electron; Miocamycin; Staphylococcus aureus | 1992 |
Comparative in vitro activity of clarithromycin. Spanish Collaborative Group.
Topics: Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1992 |
The conformation of 6-methoxyerythromycin A in water determined by proton NMR spectroscopy.
Topics: Clarithromycin; Erythromycin; Magnetic Resonance Spectroscopy; Molecular Conformation | 1992 |
Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.
Topics: Animals; Clarithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Minocycline; Toxoplasmosis, Animal | 1992 |
Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium.
Topics: Acquired Immunodeficiency Syndrome; Clarithromycin; Culture Media; Erythromycin; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Microbial Sensitivity Tests; Mycobacterium avium Complex | 1992 |
Failure of clarithromycin in preventing toxoplasmic encephalitis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Clarithromycin; Encephalitis; Erythromycin; Humans; Toxoplasmosis, Cerebral | 1992 |
Acquired resistance of MAI to clarithromycin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1992 |
Activity of clarithromycin against murine listeriosis.
Topics: Animals; Clarithromycin; Erythromycin; Female; Kinetics; Listeria monocytogenes; Listeriosis; Mice; Mice, Inbred Strains; Mice, Nude; Microbial Sensitivity Tests; Reference Values | 1992 |
Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin.
Topics: Clarithromycin; Drug Stability; Erythromycin; Hydrogen-Ion Concentration; Solubility | 1992 |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Roxithromycin | 1991 |
The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Legionella; Leucomycins; Microbial Sensitivity Tests; Mycoplasma; Roxithromycin; Staphylococcus; Ureaplasma | 1991 |
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Erythromycin; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Macrophages; Minocycline; Mycobacterium; Quinolones; Rifabutin; Rifamycins | 1991 |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Azithromycin; Cell Division; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; In Vitro Techniques; Leprostatic Agents; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Quinolones; Rifampin | 1991 |
Clinical results using two new antibiotics--clarithromycin and temafloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Opportunistic Infections; Quinolones | 1991 |
Clarithromycin-idarubicin.
Topics: Clarithromycin; Erythromycin; Humans; Idarubicin | 1991 |
A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents.
Topics: Administration, Oral; Blood Bactericidal Activity; Clarithromycin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Synergism; Erythromycin; Humans; Microbial Sensitivity Tests | 1991 |
Clarithromyocin new approaches to the treatment of respiratory tract infection. Seventh Mediterranean Congress of Chemotherapy. Barcelona, Spain, May 1990.
Topics: Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections | 1991 |
The development of macrolides: clarithromycin in perspective.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Half-Life; Humans | 1991 |
In-vitro activity of clarithromycin combined with its 14-hydroxy metabolite A-62671 against Haemophilus influenzae.
Topics: Clarithromycin; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests | 1991 |
The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in-vitro and serum bactericidal tests.
Topics: Clarithromycin; Drug Therapy, Combination; Erythromycin; Female; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Serum Bactericidal Test; Species Specificity | 1991 |
Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Lung Diseases; Mice; Mice, Inbred C57BL | 1991 |
The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR).
Topics: Anti-Bacterial Agents; Chlamydia; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Species Specificity | 1991 |
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
Topics: Cell Division; Cells, Cultured; Clarithromycin; Drug Combinations; Erythromycin; Ethambutol; Microbial Sensitivity Tests; Microscopy, Electron; Mycobacterium avium; Rifampin | 1991 |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice.
Topics: Animals; Clarithromycin; Drug Therapy, Combination; Erythromycin; Leprosy; Mice; Minocycline; Mycobacterium leprae; Rifampin | 1991 |
The in-vitro and disc susceptibility testing of clarithromycin and its 14-hydroxy metabolite.
Topics: Bacteria; Blood Proteins; Clarithromycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Erythromycin; Microbial Sensitivity Tests; Protein Binding | 1991 |
A polymer carrier system for taste masking of macrolide antibiotics.
Topics: Absorption; Acrylic Resins; Animals; Anti-Bacterial Agents; Biological Availability; Clarithromycin; Dogs; Drug Carriers; Erythromycin; Humans; Methylcellulose; Polyvinyls; Taste | 1991 |
[Clarithromycin in the treatment of respiratory infections].
Topics: Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Pneumonia; Respiratory Tract Infections | 1991 |
A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms.
Topics: Capsules; Chromatography, High Pressure Liquid; Clarithromycin; Drug Stability; Erythromycin; Hypromellose Derivatives; Injections; Methylcellulose; Spectrophotometry, Ultraviolet; Suspensions; Tablets | 1991 |
In-vitro cidal activity of clarithromycin and its 14-hydroxy metabolite (A-62671) against Haemophilus influenzae.
Topics: Clarithromycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Time Factors | 1991 |
Determination of clarithromycin as a contaminant on surfaces by high-performance liquid chromatography using electrochemical detection.
Topics: Chromatography, High Pressure Liquid; Clarithromycin; Drug Contamination; Electrochemistry; Erythromycin | 1991 |
Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae.
Topics: Clarithromycin; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 1991 |
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex.
Topics: Clarithromycin; Erythromycin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium avium Complex | 1991 |
[Clinical efficacy of clarithromycin].
Topics: Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections; Skin Diseases, Infectious | 1991 |
Clarithromycin monotherapy of MAC-mycobacteriosis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Clarithromycin; Erythromycin; Humans; Mycobacterium avium-intracellulare Infection | 1991 |
[Mycobacterium chelonei pulmonary infections. Apropos of a case].
Topics: Clarithromycin; Erythromycin; Female; Humans; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Pneumonia; Tomography, X-Ray Computed | 1991 |
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Brain; Clarithromycin; Drug Therapy, Combination; Erythromycin; Pyrimethamine; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1991 |
Bactericidal activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae and streptococcal pathogens.
Topics: Administration, Oral; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Serum Bactericidal Test; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes | 1991 |
Comparative effects of clarithromycin and erythromycin on the normal intestinal microflora.
Topics: Administration, Oral; Adult; Clarithromycin; Drug Administration Schedule; Erythromycin; Feces; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Intestines; Male; Sweden | 1991 |
[Effect of macrolide antibiotics on human serum-bactericidal sensitivity of Pseudomonas aeruginosa S-6].
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Humans; Pseudomonas aeruginosa; Serum Bactericidal Test | 1991 |
ESGAB breakpoint determination: clarithromycin.
Topics: Bacteria; Bacterial Infections; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mycoplasma pneumoniae | 1991 |
Susceptibility of Haemophilus influenzae to clarithromycin alone and in combination with its 14-hydroxy metabolite.
Topics: Clarithromycin; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests | 1991 |
Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection.
Topics: Chromatography, High Pressure Liquid; Clarithromycin; Electrochemistry; Erythromycin; Humans | 1991 |
Promising investigational drug available to AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Clarithromycin; Drugs, Investigational; Erythromycin; HIV-1; Humans; Mycobacterium avium-intracellulare Infection; Opportunistic Infections | 1991 |
In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Radiometry | 1991 |
Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Quinolones; Reproducibility of Results; Ureaplasma | 1990 |
Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
Topics: Anti-Bacterial Agents; Clarithromycin; Clindamycin; Erythromycin; Gram-Positive Bacteria; Humans; Macrolides; Microbial Sensitivity Tests; Neoplasms; Roxithromycin; Sepsis | 1990 |
Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032.
Topics: Animals; Bacteria; Clarithromycin; Dogs; Erythromycin; Hydrogen-Ion Concentration; Josamycin; Male; Mice; Mice, Inbred ICR; Rabbits; Rats; Rats, Inbred Strains; Staphylococcal Infections; Streptococcal Infections | 1990 |
Autobacteriographic studies of clarithromycin and erythromycin in mice.
Topics: Administration, Oral; Animals; Autoradiography; Carbon Radioisotopes; Clarithromycin; Erythromycin; Male; Mice; Mice, Inbred ICR; Staphylococcal Infections; Tissue Distribution | 1990 |
Chemical modification of erythromycins. VI. Structure and antibacterial activity of acid degradation products of 6-O-methylerythromycins A.
Topics: Bacteria; Clarithromycin; Erythromycin; Magnetic Resonance Spectroscopy; Molecular Structure; Structure-Activity Relationship | 1990 |
[In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
Topics: Bacteria, Anaerobic; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Regression Analysis | 1990 |
In vitro activity of tosufloxacin (A-60969) and clarithromycin (A-56268, TE-031) against resistant Haemophilus influenzae, Streptococcus pneumoniae and Branhamella catarrhalis isolates.
Topics: 4-Quinolones; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Haemophilus influenzae; In Vitro Techniques; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Streptococcus pneumoniae | 1990 |
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.
Topics: Animals; Clarithromycin; Drug Synergism; Erythromycin; Female; Gerbillinae; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests; Otitis Media | 1990 |
Microbiological and pharmacokinetic studies of acyl demycinosyltylosin and related tylosin derivatives.
Topics: Animals; Clarithromycin; Erythromycin; Male; Mice; Molecular Structure; Saimiri; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Tylosin | 1990 |
Macrolide progress.
Topics: Anti-Bacterial Agents; Bacteria; Chemical Phenomena; Chemistry; Clarithromycin; Erythromycin; Macrolides; Roxithromycin | 1990 |
Comparative study on the macrolides erythromycin and clarithromycin: antibacterial activity and influence on immune responses.
Topics: Animals; Antibody Formation; Bacteria; Chemotaxis, Leukocyte; Clarithromycin; Erythromycin; Female; Granulocytes; Haemophilus influenzae; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunoglobulin G; Immunoglobulin M; Macrophages; Male; Mice; Mice, Inbred BALB C; Phagocytosis; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 1990 |
Uptake of clarithromycin by rat lung cells.
Topics: Animals; Biological Transport; Clarithromycin; Erythromycin; In Vitro Techniques; Liver; Lung; Male; Rats; Rats, Inbred Strains | 1990 |
Synthesis and antibacterial activity of (9S)-9-dihydroclarithromycin.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Erythromycin; Molecular Structure; Oxidation-Reduction | 1990 |
[A new macrolide antibiotic, clarithromycin--synthesis, structure-activity relationship and metabolism].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Staphylococcus aureus; Structure-Activity Relationship | 1990 |
In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination against Legionella species.
Topics: Clarithromycin; Drug Therapy, Combination; Erythromycin; Legionella; Microbial Sensitivity Tests | 1990 |
Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine.
Topics: Animals; Azithromycin; Clarithromycin; Drug Interactions; Erythromycin; Pyrimethamine; Regression Analysis; Toxoplasma | 1990 |
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Erythromycin; Humans; In Vitro Techniques; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifamycins; Sulfisoxazole | 1990 |
New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Leucomycins; Lincosamides; Macrolides; Molecular Structure; Streptococcus pyogenes; Virginiamycin | 1989 |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Enoxacin; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Pefloxacin; Quinolones | 1989 |
In-vitro activity of clarithromycin (A-56268; TE-031) against gram-positive bacteria.
Topics: Bacterial Infections; Clarithromycin; Erythromycin; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms | 1989 |
Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Enoxacin; Erythromycin; Imipenem; Legionella; Leucomycins; Microbial Sensitivity Tests; Rifampin | 1989 |
[Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Clarithromycin; Erythromycin; Female; Humans; Killer Cells, Natural; Male; Middle Aged; Time Factors | 1989 |
[Clinical evaluation of clarithromycin, a new macrolide antibiotic in children].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Half-Life; Humans; Infant; Male | 1989 |
[Laboratory and clinical studies on clarithromycin in pediatrics].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Pharmacokinetic, bacteriological and clinical studies in the pediatric field on clarithromycin].
Topics: Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Half-Life; Humans; Infant; Male | 1989 |
[Basic and clinical studies on clarithromycin in pediatrics].
Topics: Age Factors; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Enterocolitis; Erythromycin; Female; Half-Life; Humans; Infant; Infant, Newborn; Male; Respiratory Tract Infections | 1989 |
[Laboratory and clinical studies on clarithromycin in the field of pediatrics].
Topics: Adolescent; Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Experience with clarithromycin in pediatric patients].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical evaluation of clarithromycin in pediatric patients].
Topics: Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Laboratory and clinical studies of clarithromycin in pediatric fields].
Topics: Age Factors; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Neutrophils; Respiratory Tract Infections | 1989 |
[Clinical study of clarithromycin, a new macrolide antibiotic, in children].
Topics: Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enterocolitis; Erythromycin; Female; Humans; Impetigo; Infant; Male; Respiratory Tract Infections | 1989 |
[A clinical study on clarithromycin especially on its granular form for children in pediatrics].
Topics: Age Factors; Child; Child, Preschool; Clarithromycin; Colitis; Dosage Forms; Drug Evaluation; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical experience with clarithromycin in the pediatric field].
Topics: Administration, Oral; Adolescent; Age Factors; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Erythromycin; Female; Humans; Impetigo; Infant; Male; Respiratory Tract Infections | 1989 |
[Basic and clinical studies on use of clarithromycin granules in pediatrics].
Topics: Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical efficacy of clarithromycin in the field of pediatrics].
Topics: Acute Disease; Administration, Oral; Age Factors; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Enteritis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical observations with clarithromycin in pediatrics].
Topics: Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enteritis; Erythromycin; Female; Humans; Male; Respiratory Tract Infections | 1989 |
[Clinical study on clarithromycin granule and tablet in the field of pediatrics].
Topics: Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male | 1989 |
[Pharmacokinetics of clarithromycin granule and tablet in children].
Topics: Administration, Oral; Adolescent; Age Factors; Child; Child, Preschool; Chromatography, High Pressure Liquid; Clarithromycin; Dosage Forms; Erythromycin; Female; Humans; Male; Tablets | 1989 |
[Pharmacokinetic and clinical studies of clarithromycin in the pediatric field].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats.
Topics: Administration, Oral; Animals; Autoradiography; Biological Assay; Chromatography, Thin Layer; Clarithromycin; Erythromycin; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1989 |
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
Topics: Animals; Clarithromycin; Cytochrome P-450 Enzyme System; Dealkylation; Dexamethasone; Enzyme Induction; Erythromycin; Iron; Isoenzymes; Male; Rats; Rats, Inbred Strains; Troleandomycin | 1989 |
[Penetration of clarithromycin to saliva and its effect on normal salivary bacterial flora].
Topics: Animals; Bacteria; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Male; Rats; Rats, Inbred Strains; Saliva; Submandibular Gland | 1989 |
Hydroxylation and N-demethylation of clarithromycin (6-O-methylerythromycin A) by Mucor circinelloides.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Clarithromycin; Erythromycin; Gram-Positive Bacteria; Hydroxylation; Microbial Sensitivity Tests; Mucor; Structure-Activity Relationship | 1989 |
A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
Topics: Animals; Anti-Bacterial Agents; Body Fluids; Clarithromycin; Erythromycin; Guinea Pigs; Josamycin; Legionella; Legionnaires' Disease; Male; Roxithromycin; Therapeutic Irrigation | 1989 |
In vitro and in vivo activities of clarithromycin against Mycobacterium avium.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1989 |
Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Cyclooxygenase Inhibitors; Erythromycin; Female; Interleukin-1; Lymphocyte Activation; Macrophages; Mice; Peritoneal Cavity; Spleen; T-Lymphocytes | 1989 |
The development of macrolides and related compounds.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Design; Erythromycin | 1989 |
Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Azithromycin; Borrelia; Clarithromycin; Erythromycin; Fluoroquinolones; Gerbillinae; Leucomycins; Lyme Disease; Microbial Sensitivity Tests; Quinolones; Species Specificity | 1989 |
Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella; Bordetella pertussis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Leucomycins; Macrolides; Microbial Sensitivity Tests | 1989 |
Crystal and molecular structure of (14R)-14-hydroxy-6-O-methylerythromycin A.
Topics: Clarithromycin; Crystallization; Erythromycin; Molecular Structure; X-Ray Diffraction | 1989 |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
Topics: Animals; Azithromycin; Clarithromycin; Erythromycin; Female; Leucomycins; Macrophages; Mice; Toxoplasma; Tritium; Uracil | 1988 |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin.
Topics: Azithromycin; Bacteria; Clarithromycin; Clindamycin; Culture Media; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Hydrogen-Ion Concentration; Leucomycins | 1988 |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Drug Combinations; Drug Synergism; Erythromycin; Female; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Injections, Subcutaneous; Kinetics; Legionella; Legionnaires' Disease; Male; Mice; Microbial Sensitivity Tests; Sulfamethoxazole | 1986 |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Combinations; Erythromycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.
Topics: Anti-Bacterial Agents; Campylobacter fetus; Clarithromycin; Clindamycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1987 |
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Clarithromycin; Clindamycin; Culture Media; Erythromycin; Leucomycins; Microbial Sensitivity Tests | 1987 |
Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
Topics: Bacteria; Clarithromycin; Culture Media; Erythromycin; Microbial Sensitivity Tests | 1987 |
Disk diffusion and disk elution tests with A-56268 and erythromycin.
Topics: Bacteria; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Predictive Value of Tests; Regression Analysis | 1987 |
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests | 1987 |
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Chlamydia trachomatis; Clarithromycin; Erythromycin; Leucomycins; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1987 |
Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.
Topics: Animals; Anti-Bacterial Agents; Chlamydia trachomatis; Clarithromycin; Erythromycin; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1987 |
Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031).
Topics: Clarithromycin; Erythromycin; Listeria monocytogenes; Microbial Sensitivity Tests; Regression Analysis; Staphylococcus; Streptococcus | 1987 |
In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Erythromycin; Microbial Sensitivity Tests | 1987 |
The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution method.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Legionella; Leucomycins; Microbial Sensitivity Tests | 1987 |
Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Culture Media; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Kinetics; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Sepsis | 1987 |
Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria | 1987 |
Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Cefotaxime; Cefoxitin; Chloramphenicol; Clarithromycin; Clindamycin; Erythromycin; Microbial Sensitivity Tests | 1987 |
Comparative in vitro activity of A-56268 against respiratory tract pathogens.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes | 1987 |
Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
Topics: Blood Proteins; Clarithromycin; Erythromycin; Leucomycins; Microbial Sensitivity Tests; Orosomucoid; Protein Binding; Staphylococcus; Streptococcus | 1987 |
Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Erythromycin; Microbial Sensitivity Tests | 1987 |
Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycin.
Topics: Biological Assay; Chromatography, High Pressure Liquid; Clarithromycin; Erythromycin; Humans; Micrococcus | 1988 |
Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
Topics: Bacteria, Aerobic; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests | 1988 |
Microbial transformation of 6-O-methylerythromycin derivatives.
Topics: Chemical Phenomena; Chemistry; Clarithromycin; Erythromycin; Hydroxylation; Molecular Conformation; Mucor | 1988 |
14-Hydroxy-6-O-methylerythromycins A, active metabolites of 6-O-methylerythromycin A in human.
Topics: Chemical Phenomena; Chemistry; Clarithromycin; Erythromycin; Humans; Molecular Conformation | 1988 |
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
Topics: Animals; Clarithromycin; Erythromycin; Female; Mice; Mice, Inbred Strains; Toxoplasma; Toxoplasmosis, Animal | 1988 |
In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Mycoplasma; Ureaplasma | 1988 |
Comparative in vitro activity of A-56268.
Topics: Anti-Infective Agents; Clarithromycin; Erythromycin; Leucomycins; Microbial Sensitivity Tests | 1988 |
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test.
Topics: Clarithromycin; Culture Media; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests | 1988 |
Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Erythromycin; Injections, Subcutaneous; Mice; Staphylococcal Infections; Streptococcal Infections | 1988 |
An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent.
Topics: Adult; Amoxicillin; Clarithromycin; Colony Count, Microbial; Erythromycin; Humans; In Vitro Techniques; Listeria; Listeria monocytogenes; Microbial Sensitivity Tests; Neutrophils; Phagocytosis; Rifampin; Staphylococcus aureus | 1988 |
Semi-automated preparation of a 11C-labelled antibiotic--[N-methyl-11C]erythromycin A lactobionate.
Topics: Carbon Radioisotopes; Clarithromycin; Erythromycin; Isotope Labeling | 1984 |
Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Erythromycin; Magnetic Resonance Spectroscopy; Methylation | 1984 |
In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Drug Evaluation, Preclinical; Drug Stability; Erythromycin; Female; Half-Life; Klebsiella Infections; Macrolides; Mice; Mice, Inbred DBA; Molecular Structure; Staphylococcal Infections; Streptococcal Infections | 1995 |
Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Netherlands; Roxithromycin; Streptococcus pyogenes | 1995 |
Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies.
Topics: Agar; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Oxygenases; Roxithromycin | 1995 |
Group A streptococci: evaluation of in vitro resistance to two macrolides.
Topics: Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carrier Proteins; Child; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Palatine Tonsil; Pharynx; Streptococcal Infections; Streptococcus pyogenes; Virulence | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus.
Topics: Acetylcholine; Anti-Bacterial Agents; Bronchoconstriction; Clarithromycin; Electric Stimulation; Erythromycin; Humans; In Vitro Techniques; Nervous System Physiological Phenomena; Roxithromycin | 1995 |
Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Erythromycin; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1994 |
Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Topics: Aluminum Chloride; Aluminum Compounds; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chalcone; Chalcones; Chlorides; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Erythromycin; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Tetracycline; Zinc Compounds | 1994 |
Erythromycin-induced carbamazepine toxicity: a continuing problem.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Clarithromycin; Drug Interactions; Epilepsy; Erythromycin; Female; Humans; Male | 1995 |
[Rhodococcus equi pneumonia in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Actinomycetales Infections; Adult; Clarithromycin; Erythromycin; Humans; Imipenem; Male; Middle Aged; Pneumonia; Rhodococcus equi; Rifampin; Vancomycin | 1994 |
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Culture Media; Erythromycin; Guidelines as Topic; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 1994 |
Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes.
Topics: Centrifugation, Density Gradient; Clarithromycin; Erythromycin; Escherichia coli; Helicobacter pylori; Indicators and Reagents; Ribosomes | 1994 |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cricetinae; Erythromycin; Lung; Male; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Roxithromycin | 1994 |
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.
Topics: Animals; Cells, Cultured; Chlorocebus aethiops; Clarithromycin; Coxiella burnetii; Erythromycin; Macrophages; Mice; Microbial Sensitivity Tests; Q Fever; Rickettsia; Rickettsia Infections; Rickettsia rickettsii; Vero Cells | 1993 |
[Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes; Time Factors | 1993 |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.
Topics: Azithromycin; Bacteria, Anaerobic; Carbon Dioxide; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Oxygenases; Roxithromycin | 1994 |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.
Topics: Animals; Azithromycin; Borrelia burgdorferi Group; Clarithromycin; Erythromycin; Humans; Kinetics; Mice; Microbial Sensitivity Tests; Ticks; Time Factors | 1993 |
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I.
Topics: Adult; Aged; Bacteremia; Child; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumococcal Infections; Rhode Island; Streptococcus pneumoniae | 1993 |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance.
Topics: Azithromycin; Clarithromycin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Fusobacterium; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Pasteurella multocida; Regression Analysis; Staphylococcus; Statistics as Topic; Streptococcus | 1993 |
Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives.
Topics: Clarithromycin; Erythromycin | 1993 |
Two new macrolide antibiotics: clarithromycin and azithromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Drug Costs; Erythromycin; Humans | 1993 |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria.
Topics: Azithromycin; Cell Membrane; Clarithromycin; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Lipopolysaccharides; Microbial Sensitivity Tests; Polymyxins; Roxithromycin; Salmonella typhimurium | 1993 |
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Quinolones | 1993 |
In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Fluoroquinolones; Giardia lamblia; Metronidazole; Microbial Sensitivity Tests; Quinolones | 1993 |
Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Doxycycline; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Mice, Inbred BALB C; Minocycline; Paromomycin; Tetracyclines | 1993 |
Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Movement; Clarithromycin; Erythromycin; Hemolysin Proteins; Humans; Lipase; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Virulence | 1993 |
A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease.
Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Female; Guinea Pigs; Legionella pneumophila; Legionnaires' Disease; Lung | 1993 |
The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Endocarditis, Bacterial; Erythromycin; Female; Gerbillinae; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Otitis Media; Pneumococcal Infections; Pneumonia; Rats; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin.
Topics: Clarithromycin; Erythromycin; Methylation | 1993 |
Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Bacterial Agents; Base Sequence; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Peptidyl Transferases; Ribosomes; RNA, Messenger | 1995 |
[The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Injections, Subcutaneous; Mice; Pneumonia, Pneumococcal; Roxithromycin; Spiramycin | 1995 |
Use of terfenadine and contraindicated drugs.
Topics: Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Contraindications; Drug Interactions; Drug Utilization; Erythromycin; Histamine H1 Antagonists; Humans; Itraconazole; Ketoconazole; Pharmaceutical Services; Product Labeling; Retrospective Studies; Terfenadine; Troleandomycin | 1996 |
Effect of clarithromycin on the bioavailability of cyclosporin in rats.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Clarithromycin; Cyclosporine; Cyclosporins; Drug Interactions; Erythromycin; Gastric Emptying; Infusions, Intravenous; Male; Rats; Rats, Wistar | 1996 |
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Tetracycline | 1996 |
Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Evaluation Studies as Topic; Gonorrhea; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1996 |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; United States | 1996 |
Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Carboxylic Ester Hydrolases; Clarithromycin; Erythromycin; Escherichia coli; Roxithromycin | 1996 |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clindamycin; Colony Count, Microbial; Endocarditis, Bacterial; Erythromycin; Rats; Serum Bactericidal Test; Streptococcal Infections | 1996 |
Effect of macrolide antibiotics on macrophage functions.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Chemotaxis; Clarithromycin; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Erythromycin; Macrophages; Mice; Phagocytosis; Roxithromycin | 1996 |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Time Factors; Virginiamycin | 1996 |
Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Epithelial Cells; Epithelium; Erythromycin; Humans; Liver; Proteins; Roxithromycin; Tetrazolium Salts; Thiazoles | 1996 |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Clarithromycin; Erythromycin; Kinetics; Microbial Sensitivity Tests; Protein Synthesis Inhibitors; Pseudomonas aeruginosa | 1996 |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 1996 |
Analysis of macrolide antibiotics by capillary electrophoresis.
Topics: Acetonitriles; Anti-Bacterial Agents; Buffers; Carbohydrate Sequence; Cholic Acid; Cholic Acids; Clarithromycin; Electrophoresis, Capillary; Erythromycin; Molecular Sequence Data; Molecular Structure; Oleandomycin; Spiramycin; Troleandomycin | 1996 |
In vitro activity of macrolides against intracellular Legionella pneumophila.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Clarithromycin; Erythromycin; Humans; Legionella pneumophila; Legionnaires' Disease; Microbial Sensitivity Tests | 1996 |
Effect of sub-inhibitory concentrations of clarithromycin and erythromycin on the production of Staphylococcus aureus capsules.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Clarithromycin; Erythromycin; Staphylococcus aureus | 1995 |
Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5.
Topics: Aminophylline; Animals; Apoptosis; Cell Survival; Cells, Cultured; Clarithromycin; Drug Antagonism; Eosinophils; Erythromycin; Glucocorticoids; Guinea Pigs; Humans; Interleukin-5; Macrolides; Methylprednisolone; Peritoneal Lavage; Theophylline | 1996 |
Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils.
Topics: Adult; Anti-Asthmatic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Azithromycin; Calcimycin; Cell Membrane; Clarithromycin; Erythromycin; Humans; Ionophores; Luminescent Measurements; Lysophosphatidylcholines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Respiratory Burst; Roxithromycin; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1996 |
Inhibitory and bactericidal activity of rokitamycin against Helicobacter pylori and morphological alterations.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Helicobacter pylori; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Miocamycin | 1996 |
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Clindamycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Intestinal Mucosa; Jejunum; Kinetics; Mice; Microsomes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Reference Values; Time Factors; Toxoplasmosis, Animal | 1996 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Carrier State; Cefaclor; Cefuroxime; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Infant; Microbial Sensitivity Tests; Penicillins; Spain; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel.
Topics: Anti-Bacterial Agents; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Israel; Penicillins; Streptococcal Infections; Streptococcus pyogenes | 1997 |
[Effect of erythromycin and clarithromycin on ion transport across dissected canine tracheal epithelium].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Dogs; Epithelium; Erythromycin; In Vitro Techniques; Ion Transport; Trachea | 1997 |
Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes.
Topics: Anti-Bacterial Agents; Azithromycin; Calcium; Clarithromycin; Drug Evaluation, Preclinical; Erythromycin; Humans; Hydrogen-Ion Concentration; Macrophages, Alveolar; Monocytes; Neutrophils; Phagocytes; Temperature | 1997 |
Effects of erythromycin, clarithromycin and rokitamycin on nifedipine metabolism in rats.
Topics: Animals; Anti-Bacterial Agents; Calcium Channel Blockers; Clarithromycin; Drug Interactions; Erythromycin; In Vitro Techniques; Intestinal Absorption; Jugular Veins; Male; Microsomes, Liver; Miocamycin; Nifedipine; Portal Vein; Rats; Rats, Wistar | 1997 |
The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteroides fragilis; Chlamydia; Ciprofloxacin; Clarithromycin; Doxycycline; Enterobacter; Erythromycin; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae | 1997 |
Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence | 1996 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
In vitro anti-Helicobacter pylori activity of ebrotidine.
Topics: Amoxicillin; Benzenesulfonates; Clarithromycin; Drug Synergism; Erythromycin; Helicobacter pylori; Histamine H2 Antagonists; Metronidazole; Microbial Sensitivity Tests; Ranitidine; Tetracycline; Thiazoles | 1997 |
[Suppressive effect of clarithromycin on the production of verotoxin by E. coli O157].
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Erythromycin; Escherichia coli O157; Shiga Toxin 1; Shiga Toxin 2 | 1997 |
Comparison of Etest and agar dilution for testing the activity of three macrolides against Bordetella parapertussis.
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Bordetella; Child; Clarithromycin; Erythromycin; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests | 1997 |
Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; United States | 1997 |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Clindamycin; Endocarditis, Bacterial; Erythromycin; Rabbits; Streptococcus | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae | 1997 |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Erythromycin; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Roxithromycin; Streptococcus pneumoniae | 1997 |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Carbon Dioxide; Clarithromycin; Erythromycin; Hydrogen-Ion Concentration; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin | 1997 |
Clarithromycin-induced ventricular tachycardia.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Electrocardiography; Emergencies; Erythromycin; Female; Humans; Structure-Activity Relationship; Tachycardia, Ventricular | 1997 |
Neutrophil-induced endothelial cell damage: inhibition by a 14-membered ring macrolide through the action of nitric oxide.
Topics: Anti-Bacterial Agents; Benzoates; Calcium; Cells, Cultured; Clarithromycin; Endothelium, Vascular; Erythromycin; Humans; Imidazoles; L-Lactate Dehydrogenase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Nitric Oxide; Pulmonary Artery; Superoxides | 1997 |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Charcoal; Ciprofloxacin; Clarithromycin; Culture Media; Erythromycin; Humans; Legionella; Legionella pneumophila; Legionellosis; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; Starch | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin; Streptococcus pneumoniae | 1997 |
[Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Enterococcus; Erythromycin; Gram-Positive Cocci; Humans; Methicillin Resistance; Roxithromycin; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes; Virginiamycin | 1997 |
[Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Hypersensitivity; Drug Resistance, Microbial; Erythromycin; Israel; Microbial Sensitivity Tests; Penicillins; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1997 |
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations.
Topics: Anti-Bacterial Agents; Base Sequence; Clarithromycin; Cloning, Molecular; DNA; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Helicobacter pylori; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleic Acid Conformation; Phylogeny; Point Mutation; Polymerase Chain Reaction; RNA, Ribosomal, 23S; Transformation, Genetic | 1997 |
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Microbiological Techniques; Middle Aged; Nitroimidazoles; Tetracycline | 1997 |
[Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Leucomycins; Pseudomonas aeruginosa | 1998 |
Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Chemical Fractionation; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Ribosomes; Structure-Activity Relationship | 1998 |
Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Erythromycin; HL-60 Cells; Humans; Legionella; Legionella pneumophila; Macrolides; Microbial Sensitivity Tests; Monocytes; Roxithromycin; Virginiamycin | 1998 |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella; Bordetella pertussis; Clarithromycin; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Rifabutin; Rifampin; Roxithromycin | 1998 |
Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Gram-Negative Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Oxygenases | 1998 |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated f
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bites, Human; Clarithromycin; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin; Skin Diseases, Bacterial; Soft Tissue Infections; Wounds and Injuries | 1998 |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1998 |
[Effects of macrolide antibiotics to inhibit infiltration and proliferation of malignant tumor cells--in vitro evaluation].
Topics: Anti-Bacterial Agents; Azithromycin; Cell Division; Cell Line; Clarithromycin; Erythromycin; Fibrosarcoma; Humans; Immunologic Factors; Neoplasm Invasiveness; Roxithromycin; Teratocarcinoma; Tumor Cells, Cultured | 1997 |
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Survival Rate | 1997 |
[Il-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics].
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cells, Cultured; Clarithromycin; Dexamethasone; Epithelial Cells; Erythromycin; Glucocorticoids; Humans; Interleukin-8; Josamycin; Nasal Mucosa; Roxithromycin | 1997 |
[Actions of macrolide antibiotics on alginate production by Pseudomonas aeruginosa].
Topics: Alginates; Animals; Anti-Bacterial Agents; Antigen-Antibody Complex; Azithromycin; Clarithromycin; Erythromycin; Humans; Leucomycins; Macrolides; Mice; Pseudomonas aeruginosa; Roxithromycin | 1997 |
[Quantitative evaluation of the inhibitory action of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Erythromycin; Leucomycins; Macrolides; Microscopy, Electron, Scanning; Polysaccharides, Bacterial; Pseudomonas aeruginosa | 1997 |
[Effects and actions of EM (erythromycin), CAM (clarithromycin), and JM (josamycin) on IL-4 and IL-5 production by monocytes].
Topics: Adult; Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Erythromycin; Female; Humans; Interleukin-4; Interleukin-5; Josamycin; Male; Monocytes | 1997 |
[Study of therapeutic effects of macrolide antibiotics on patients with anti-HTLV-1 antibody positive DPB (diffuse panbronchitis)].
Topics: Anti-Bacterial Agents; Bronchitis; Clarithromycin; Erythromycin; Female; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Roxithromycin | 1997 |
[Effects of macrolide drugs on endogenous glucocorticoids].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Dexamethasone; Erythromycin; Glucocorticoids; Josamycin; Mice | 1997 |
[Study of suppression of neutrophil functions and prevention of vascular endothelial injury by macrolide antibiotics].
Topics: Anti-Bacterial Agents; Calcium; Clarithromycin; Endothelium, Vascular; Erythromycin; Humans; In Vitro Techniques; Neutrophils; Roxithromycin; Superoxides | 1998 |
[Effects of macrolide antibiotics on iNOS gene expression and NO production by alveolar macrophages].
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Erythromycin; Gene Expression; Josamycin; Macrophages, Alveolar; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1998 |
[Mucous pathology and macrolide treatment of paranasal sinusitis in children].
Topics: Adolescent; Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Erythromycin; Humans; Mucous Membrane; Sinusitis | 1998 |
[Effect of macrolides on IL-8 gene expression by cultured airway epithelial cells].
Topics: Anti-Bacterial Agents; Bronchi; Cells, Cultured; Clarithromycin; Erythromycin; Gene Expression; Humans; Interleukin-8; RNA, Messenger | 1998 |
[Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation].
Topics: Anti-Bacterial Agents; Asthma; Clarithromycin; Eosinophils; Erythromycin; Fosfomycin; Humans; Hypersensitivity; Immunosuppressive Agents; In Vitro Techniques; Interleukin-8; Josamycin; Tacrolimus | 1998 |
[Inhibition of neutrophil-derived IL-8 production caused by EM (erythromycin) 201 derivative: modification of the activities by the 5-position desosamine side chain].
Topics: Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Erythromycin; Humans; Interleukin-8; Neutrophils; Structure-Activity Relationship | 1998 |
[Study on bacterial biofilm destruction by various antibacterial agents].
Topics: Anti-Bacterial Agents; Biofilms; Cefotiam; Cephalosporins; Clarithromycin; Erythromycin; Miocamycin; Staphylococcus aureus | 1998 |
[Inhibitory effects of macrolide antibiotics at low concentrations on vero toxin production by pathogenic E. coli O157].
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Clarithromycin; Enterotoxins; Erythromycin; Escherichia coli O157; Penicillins; Shiga Toxin 1 | 1998 |
[Effects of macrolides on intracellular Ca2+ response by airway epithelium].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bronchi; Calcium; Cattle; Cefazolin; Cephalosporins; Clarithromycin; Epithelial Cells; Erythromycin; In Vitro Techniques; Penicillins | 1998 |
Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Cross Reactions; Erythromycin; Female; Humans; Intradermal Tests; Roxithromycin; Urticaria | 1998 |
[Antimicrobial activity of macrolides against clinical isolates].
Topics: Anti-Bacterial Agents; Campylobacter jejuni; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Humans; Moraxella catarrhalis; Peptostreptococcus; Roxithromycin; Streptococcus pneumoniae; Streptococcus pyogenes | 1998 |
[Drug susceptibility of clinically isolated Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Cross Reactions; Drug Resistance, Microbial; Erythromycin; Gastritis; Helicobacter pylori; Humans; Imipenem; Penicillins; Stomach Ulcer; Thienamycins | 1998 |
[Evaluation of methods of macrolide antibiotic administration in experimental otitis media of rats].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Male; Otitis Media with Effusion; Rats; Rats, Sprague-Dawley | 1997 |
[Effect of macrolide antibiotics on ion transport of nasal mucosal epithelium].
Topics: Anti-Bacterial Agents; Clarithromycin; Epithelium; Erythromycin; Humans; In Vitro Techniques; Ion Transport; Nasal Mucosa; Roxithromycin | 1997 |
Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells.
Topics: Adult; Aged; Anti-Bacterial Agents; Asthma; Bronchi; Cell Line, Transformed; Clarithromycin; Culture Techniques; Cytokines; Endothelin-1; Epithelial Cells; Erythromycin; Female; Gene Expression; Humans; Male; Middle Aged; RNA, Messenger | 1998 |
Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Clarithromycin; Disease Models, Animal; Erythromycin; Fasciitis, Necrotizing; Mice; Mice, Hairless; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes | 1998 |
[Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Leucomycins; Methicillin Resistance; Miocamycin; Moraxella catarrhalis; Mycoplasma pneumoniae; Penicillin Resistance; Penicillins; Roxithromycin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1997 |
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Periodontitis | 1998 |
Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Methicillin Resistance; Microbial Sensitivity Tests; Protein Biosynthesis; Ribosomes; Staphylococcus aureus | 1998 |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 1998 |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Point Mutation; RNA, Ribosomal, 23S | 1999 |
[Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study].
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus; Tonsillitis | 1999 |
Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells.
Topics: Anti-Bacterial Agents; Bronchi; Cell Line; Clarithromycin; Colony Count, Microbial; Epithelial Cells; Erythromycin; Gastrointestinal Motility; Humans; Interleukin-8; Stimulation, Chemical; Structure-Activity Relationship | 1999 |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors.
Topics: Anti-Bacterial Agents; Clarithromycin; Eosinophils; Erythromycin; Humans; Immunohistochemistry; Interleukin-8; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 1999 |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Gatifloxacin; Legionella; Microbial Sensitivity Tests; Rifampin | 1999 |
Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Erythromycin; Ribosomes; Staphylococcus aureus | 1999 |
Clarithromycin for experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Erythromycin; Keratitis; Minocycline; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 1999 |
Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Greece; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Phenotype; Streptococcus | 1999 |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents.
Topics: Anti-Bacterial Agents; Azithromycin; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Hydrogen-Ion Concentration; Lung Diseases, Obstructive; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Sputum; Streptococcus pneumoniae | 1999 |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; beta-Lactamases; Clarithromycin; Clindamycin; Drug Therapy, Combination; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Ketolides; Macrolides; Metronidazole; Microbial Sensitivity Tests; Roxithromycin; Virginiamycin | 1999 |
Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bulgaria; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Female; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Time Factors | 1999 |
Impact of a Web-based clinical information system on cisapride drug interactions and patient safety.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Antifungal Agents; Azoles; Cisapride; Clarithromycin; Clinical Pharmacy Information Systems; Drug Information Services; Drug Interactions; Erythromycin; Gastrointestinal Agents; Humans; Internet; Retrospective Studies | 1999 |
[Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Male; Organ Specificity; Rats; Rats, Wistar; Roxithromycin | 1999 |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7.
Topics: Animals; Anti-Infective Agents; Azithromycin; Bacterial Toxins; Chlorocebus aethiops; Clarithromycin; Dose-Response Relationship, Drug; Enterotoxins; Erythromycin; Escherichia coli O157; Fluoroquinolones; Humans; Macrolides; Norfloxacin; Piperazines; Quinolones; Shiga Toxin 1; Time Factors; Vero Cells | 1999 |
Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 1999 |
Anti-inflammatory activity of macrolide antibiotics.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenalectomy; Anesthesia; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Carrageenan; Cell Line; Clarithromycin; Cyclooxygenase 2; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Erythromycin; Inflammation Mediators; Isoenzymes; Leukotriene B4; Macrophages; Mice; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pleurisy; Prostaglandin-Endoperoxide Synthases; Rats; Roxithromycin; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
A new convenient transformation of erythromycin A into clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Magnetic Resonance Spectroscopy; Methods | 1999 |
Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy.
Topics: Acids; Anti-Bacterial Agents; Catalysis; Clarithromycin; Erythromycin; Kinetics; Magnetic Resonance Spectroscopy; Solubility | 2000 |
Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cefaclor; Clarithromycin; Dose-Response Relationship, Drug; Erythromycin; Gene Expression Regulation, Enzymologic; Humans; Josamycin; Macrophages, Alveolar; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2000 |
[Effect of macrolides on ligand expression by T lymphocytes obtained from human peripheral blood].
Topics: Anti-Bacterial Agents; CD28 Antigens; CD4 Antigens; Cells, Cultured; Clarithromycin; Erythromycin; Humans; Ligands; Lymphocyte Function-Associated Antigen-1; Receptors, Interleukin-2; Roxithromycin; T-Lymphocytes | 2000 |
[Effects of 14-member cyclic macrolide compounds on rat leukocyte chemotaxis].
Topics: Animals; Anti-Bacterial Agents; Chemotaxis, Leukocyte; Clarithromycin; Erythromycin; Male; Rats; Rats, Sprague-Dawley; Roxithromycin; Structure-Activity Relationship | 2000 |
[Effects of macrolides on several transcription factors].
Topics: Anti-Bacterial Agents; Bronchi; Cells, Cultured; Clarithromycin; Dexamethasone; Epithelial Cells; Erythromycin; Humans; NF-kappa B; Transcription Factor AP-1 | 2000 |
Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
Topics: Anti-Bacterial Agents; Base Sequence; Binding Sites; Clarithromycin; Drug Interactions; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Protein Synthesis Inhibitors; Ribosomes; RNA, Ribosomal, 23S | 2000 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Glycogen; Humans; Male; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Plasmids; Urethritis | 2000 |
Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cells, Cultured; Child; Chronic Disease; Clarithromycin; Drug Administration Schedule; Epithelium; Erythromycin; Humans; Interleukin-1; Interleukin-8; Middle Aged; Nasal Mucosa; Neutrophils; Nose; Sinusitis | 2000 |
Treatment of Chlamydia pneumoniae.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibodies, Bacterial; Azithromycin; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Pneumonia, Bacterial | 2000 |
Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.
Topics: Animals; Anti-Bacterial Agents; Cell Count; Clarithromycin; Erythromycin; Ketolides; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Spleen | 2000 |
The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate.
Topics: Administration, Oral; Animals; Antiemetics; Area Under Curve; Benzamides; Benzyl Compounds; Cimetidine; Cisapride; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dealkylation; Enzyme Stability; Erythromycin; Hot Temperature; Isoenzymes; Ketoconazole; Male; Microsomes, Liver; Mixed Function Oxygenases; Morpholines; Oxygen; Oxygenases; Rats; Rats, Sprague-Dawley | 2000 |
Failure to produce detectable antibodies to Legionella pneumophila by an immunocompetent adult.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Cefotaxime; Cephalosporins; Clarithromycin; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Erythromycin; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunocompetence; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Penicillins; Sputum; Travel; Turkey; United Kingdom | 2000 |
[Influence of macrolide therapy on microorganism of chronic respiratory tract infections].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Respiratory Tract Infections; Roxithromycin; Streptococcus pneumoniae | 2000 |
Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Penicillin Resistance; Piperazines; Quinolines; Streptococcus pneumoniae; Streptococcus pyogenes; Time Factors | 2000 |
[Phlebitis due to intravenous administration of macrolide antibiotics. A comparative study of erythromycin versus clarithromycin].
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Phlebitis; Prospective Studies | 2001 |
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin | 2001 |
The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Multiple; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae | 2001 |
In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Cells, Cultured; Chlamydia trachomatis; Clarithromycin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Roxithromycin; Tetracycline | 2001 |
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple; Enterococcus; Erythromycin; Helicobacter pylori; Humans; Ketolides; Microbial Sensitivity Tests; Staphylococcus; Streptococcus; Time Factors | 2001 |
Madura foot: treatment of Nocardia nova infection with antibiotics alone.
Topics: Administration, Oral; Adult; Amikacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Foot Bones; Foot Dermatoses; Humans; Infusions, Intravenous; Nocardia; Nocardia Infections; Obesity, Morbid; Severity of Illness Index; Treatment Outcome | 2001 |
[Effects of macrolides on cultured rat vascular cells].
Topics: Animals; Anti-Bacterial Agents; Cell Adhesion; Cells, Cultured; Clarithromycin; Endothelium, Vascular; Erythromycin; Intercellular Adhesion Molecule-1; Interleukin-8; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2001 |
3-Keto-9-O-substituted oxime derivatives of 6-O-methyl erythromycin A synthesis and in vitro activity.
Topics: Anti-Bacterial Agents; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2001 |
In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Colony Count, Microbial; Drug Resistance, Microbial; Erythromycin; France; Humans; Josamycin; Leucomycins; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Roxithromycin; Streptococcus pyogenes | 2001 |
Reversible ototoxic effect of azithromycin and clarithromycin on transiently evoked otoacoustic emissions in guinea pigs.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Guinea Pigs; Injections, Intravenous; Otoacoustic Emissions, Spontaneous | 2001 |
Gene expression profiles of human small airway epithelial cells treated with low doses of 14- and 16-membered macrolides.
Topics: Anti-Bacterial Agents; Bronchi; Cells, Cultured; Clarithromycin; Epithelial Cells; Erythromycin; Gene Expression; Gene Expression Profiling; Humans; Josamycin; Oligonucleotide Array Sequence Analysis | 2001 |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae an
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes | 2001 |
Comparative in vitro activity of ABT-773 and two macrolides against staphylococci.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Staphylococcus | 2002 |
Erythromycin and clarithromycin modulation of growth factor-induced expression of heparanase mRNA on human lung cancer cells in vitro.
Topics: Anti-Bacterial Agents; Cell Movement; Clarithromycin; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Glucuronidase; Hepatocyte Growth Factor; Humans; Immunologic Factors; Lung Neoplasms; Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2001 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
Evaluation of the activity of antimicrobial agents against Legionella pneumophila multiplying in a human monocytic cell line, THP-1, and an alveolar epithelial cell line, A549.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cell Line; Ciprofloxacin; Clarithromycin; Erythromycin; Humans; Legionella pneumophila; Macrophages; Microbial Sensitivity Tests; Respiratory Mucosa | 2000 |
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Pharynx; Polymerase Chain Reaction; Streptococcal Infections; Streptococcus | 2002 |
Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Diffusion; Erythromycin; Genotype; Helicobacter pylori; Microbial Sensitivity Tests; Phenotype; Reproducibility of Results | 2002 |
Effects of erythromycin, clarithromycin, roxithromycin and azithromycin on murine gut colonization by Candida albicans.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Candida albicans; Candidiasis; Clarithromycin; Digestive System; Drug Therapy, Combination; Erythromycin; Mice; Mice, Inbred ICR; Roxithromycin; Tissue Distribution | 2002 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clarithromycin; Confidence Intervals; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Random Amplified Polymorphic DNA Technique; Reunion; Stomach Ulcer; Tetracycline; Treatment Failure | 2002 |
Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Apoptosis; Azithromycin; Cell Survival; Cells, Cultured; Clarithromycin; Collagen Type I; Dose-Response Relationship, Drug; Erythromycin; Fibroblasts; Gene Expression; Humans; Josamycin; Lethal Dose 50; Leucomycins; Miocamycin; Periodontal Ligament; RNA, Messenger; Roxithromycin; Statistics as Topic; Time Factors | 2002 |
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Clarithromycin; Electrocardiography; Erythromycin; Heart; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Rabbits; Time Factors; Torsades de Pointes | 2002 |
Comparison of telithromycin, a new ketolide, with erythromycin and clarithromycin for the treatment of Haemophilus influenzae pneumonia in suckling, middle aged and senescent mice.
Topics: Aging; Animals; Animals, Suckling; Anti-Bacterial Agents; Area Under Curve; Clarithromycin; Drug Administration Schedule; Drug Evaluation, Preclinical; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Macrolides; Mice; Pneumonia, Bacterial; Tissue Distribution | 2002 |
Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Binding Sites; Cations; Clarithromycin; Erythromycin; Kinetics; Lung; Male; Models, Chemical; Perfusion; Rats; Rats, Wistar; Time Factors | 2002 |
[Macrolide consumption according to geographic areas in the province of Valladolid].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Utilization Review; Erythromycin; Humans; Leucomycins; Retrospective Studies; Roxithromycin; Spain; Spiramycin | 2002 |
[Effect of macrolide antibiotics on MUC5AC production in human bronchial epithelial cells].
Topics: Anti-Bacterial Agents; Bronchi; Cells, Cultured; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Epithelial Cells; Erythromycin; Humans; I-kappa B Proteins; Lipopolysaccharides; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mucin 5AC; Mucins; NF-KappaB Inhibitor alpha; Phosphorylation; Transforming Growth Factor alpha | 2001 |
[Effect of macrolide antibiotics on mucus secretion from cultured epithelial cells of nasal mucosa].
Topics: Anti-Bacterial Agents; Cells, Cultured; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Erythromycin; Humans; Josamycin; Mucin 5AC; Mucins; Mucus; Nasal Mucosa | 2001 |
[Effects of erythromycin and clarithromycin on chloride channels in bronchial epithelial cells].
Topics: Anti-Bacterial Agents; Bronchi; Calcium; Cells, Cultured; Chloride Channels; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Epithelial Cells; Erythromycin; Humans; Ion Channel Gating | 2001 |
[Effect of 14-membered ring macrolides on heparanase mRNA expression in lung cancer cells].
Topics: Anti-Bacterial Agents; Cell Movement; Clarithromycin; Erythromycin; Fibroblast Growth Factor 2; Gene Expression; Glucuronidase; Hepatocyte Growth Factor; Humans; Lung Neoplasms; Platelet-Derived Growth Factor; RNA, Messenger; Tumor Cells, Cultured | 2001 |
[Anti-microbial sensitivities of bacteria isolated from patients with chronic lower respiratory tract infection under long-term macrolide therapy].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Pseudomonas aeruginosa; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Erythromycin; Female; Mice; Microbial Sensitivity Tests; Models, Animal; Peritonitis; Soft Tissue Infections; Streptococcal Infections; Streptococcus pneumoniae; Thigh; Treatment Outcome | 2002 |
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
Topics: Adult; Aged; Amitriptyline; Anti-Bacterial Agents; Anti-Infective Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clarithromycin; Cohort Studies; Drug Prescriptions; Drug Synergism; Erythromycin; Female; Fluoxetine; Heart Conduction System; Humans; Male; Middle Aged; Ofloxacin; Outpatients; Polypharmacy; Torsades de Pointes; United States | 2003 |
Need for equivalence testing of efficacy of alternative antibiotics for treatment of pertussis.
Topics: Bordetella pertussis; Clarithromycin; Clinical Trials as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Needs Assessment; Sensitivity and Specificity; Therapeutic Equivalency; Treatment Outcome; Whooping Cough | 2003 |
Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Erythromycin; Kinetics; Ribosomes; Roxithromycin | 2003 |
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer | 2002 |
[Effects of 14-, 15-, and 16-membered ring macrolides on IL-8 gene expression in BET-1A cells].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchi; Cells, Cultured; Clarithromycin; Depression, Chemical; Epithelial Cells; Erythromycin; Gene Expression; Humans; Inflammation Mediators; Interleukin-8; Miocamycin; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2001 |
[Effects of macrolide antibiotics on phagocytosis of apoptosis neutrophils by monocyte-derived macrophages].
Topics: Anti-Bacterial Agents; Apoptosis; Cells, Cultured; Clarithromycin; Complement System Proteins; Erythromycin; Humans; Macrophages; Monocytes; Neutrophils; Phagocytosis | 2001 |
[Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
Topics: Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Pharyngitis; Spain; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes.
Topics: Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Cytochrome P-450 CYP3A; Drug Interactions; Erythromycin; Humans; Hydroxylation; Macrolides; Microsomes, Liver; Midazolam; Models, Biological; Oxidoreductases, N-Demethylating; Time Factors | 2003 |
High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Clarithromycin; DNA Primers; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Ribosomes; Streptococcus pneumoniae | 2003 |
In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities.
Topics: Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Erythromycin; Greece; Ketolides; Macrolides; Streptococcus pneumoniae; Streptococcus pyogenes | 2003 |
[Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Miocamycin; Moraxella catarrhalis; Staphylococcus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 2003 |
In vitro susceptibility of nocardia species to cethromycin, clarithromycin and amikacin.
Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Nocardia; Sampling Studies; Sensitivity and Specificity | 2004 |
Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel.
Topics: Action Potentials; Anti-Bacterial Agents; Cell Line; Clarithromycin; Dose-Response Relationship, Drug; Electrophysiology; ERG1 Potassium Channel; Erythromycin; Ether-A-Go-Go Potassium Channels; Humans; Inhibitory Concentration 50; Macrolides; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Voltage-Gated; Temperature; Transfection | 2003 |
[Effect of macrolide antibiotics on expression of transcription factors and surface markers in macrophages].
Topics: Animals; Anti-Bacterial Agents; Antigens, Surface; Cells, Cultured; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Erythromycin; Gene Expression; Interferon Regulatory Factors; Macrophages; Membrane Glycoproteins; Mice; Receptors, Cell Surface; Repressor Proteins; Toll-Like Receptors; Transcription Factors | 2003 |
[Effect of macrolide antibiotics on phagocytic clearance of apoptotic neutrophils by alveolar macrophages].
Topics: Anti-Bacterial Agents; Apoptosis; Cells, Cultured; Clarithromycin; Dexamethasone; Erythromycin; Humans; Macrophages, Alveolar; Neutrophils; Phagocytosis; Structure-Activity Relationship | 2003 |
Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Clarithromycin; Enoxacin; Epithelial Cells; Erythromycin; Fibroblast Growth Factors; Gingiva; Humans; Integrins; Keratins; Laminin; Lethal Dose 50; Minocycline; Ofloxacin; Proteins; Roxithromycin; Tetracycline | 2004 |
[Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Pharynx; Phenotype; Streptococcus pyogenes | 2003 |
Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S.
Topics: Anti-Bacterial Agents; Blotting, Southern; Clarithromycin; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Haemophilus influenzae; Macrolides; Microbial Sensitivity Tests; Multigene Family; Oligonucleotide Array Sequence Analysis; Protein Conformation; Ribosomal Proteins; RNA, Bacterial; Transformation, Bacterial | 2004 |
Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Topics: Anti-Bacterial Agents; Austria; Azithromycin; Bacterial Proteins; beta-Lactams; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Hungary; Josamycin; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Pharyngitis; Pharynx; Skin; Streptococcal Infections; Streptococcus pyogenes; Tetracycline Resistance; Tonsillitis; Vagina | 2004 |
Structure-activity relationships for three macrolide antibiotics in Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Erythromycin; Haemophilus influenzae; Macrolides; Ribosomal Proteins; Roxithromycin; Structure-Activity Relationship | 2004 |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Arrhythmias, Cardiac; Case-Control Studies; Ciprofloxacin; Clarithromycin; Cohort Studies; Community Health Planning; Databases, Factual; Drug Monitoring; Erythromycin; Humans; Italy; Levofloxacin; Miocamycin; Norfloxacin; Ofloxacin; Pharmacoepidemiology; Risk Factors | 2005 |
[Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; France; Humans; Macrolides; Penicillins; Streptococcal Infections; Streptococcus pyogenes | 2004 |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Streptococcus pneumoniae; Time Factors | 2004 |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Ribosomal Proteins; RNA, Ribosomal, 23S; Time Factors | 2004 |
Effect of formulary policy decisions on antimicrobial drug utilization in British Columbia.
Topics: Anti-Bacterial Agents; Antiviral Agents; British Columbia; Clarithromycin; Erythromycin; Formularies as Topic; Health Policy; Humans; Policy Making; Practice Patterns, Physicians'; Public Health | 2005 |
Comparative study of pharmacokinetic parameters between clarithromycin and erythromycin stearate in relation to their physicochemical properties.
Topics: Anti-Bacterial Agents; Biological Availability; Clarithromycin; Drug Stability; Erythromycin; Half-Life; Humans; Intestinal Absorption; Models, Chemical | 1998 |
[Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
Topics: Anti-Bacterial Agents; Child; China; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; Penicillins; Phenotype; Spiramycin; Streptococcal Infections; Streptococcus pneumoniae | 2004 |
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Pneumonia, Bacterial | 2005 |
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome | 2005 |
Macrolide resistance of Streptococcus pneumoniae isolated during long-term macrolide therapy: difference between erythromycin and clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Retrospective Studies; Streptococcus pneumoniae | 2005 |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Dogs; Epithelial Cells; Erythromycin; Humans; Ketolides; Macrolides; Mice; Neutrophils; Phagocytes | 2005 |
Drug eruptions in children with ENT infections.
Topics: Acetaminophen; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Child; Child, Preschool; Clarithromycin; Clindamycin; Diagnosis, Differential; Drug Eruptions; Erythromycin; Female; Humans; Infant; Infections; Male; Otitis; Otorhinolaryngologic Diseases; Pharyngitis; Prospective Studies; Rhinitis; Risk Factors; Sinusitis; Stomatognathic Diseases; Tonsillitis | 2006 |
[New treatment not based on MIC for infectious diseases--making use of experience of macrolide long-term therapy].
Topics: Adult; Aged; Aged, 80 and over; Animals; Bronchiectasis; Bronchitis, Chronic; Clarithromycin; Erythromycin; Female; Humans; Lung Neoplasms; Macrolides; Male; Mice; Middle Aged | 2005 |
Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Community-Acquired Infections; Drug Prescriptions; Erythromycin; Hong Kong; Humans; Infant; Penicillin Resistance; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Prevalence; Streptococcus pneumoniae | 2005 |
Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations.
Topics: Anti-Bacterial Agents; Campylobacter; Clarithromycin; Dipeptides; DNA, Ribosomal; Drug Resistance, Multiple, Bacterial; Erythromycin; Ketolides; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation | 2005 |
Prediction of time-dependent CYP3A4 drug-drug interactions: impact of enzyme degradation, parallel elimination pathways, and intestinal inhibition.
Topics: Algorithms; Area Under Curve; Azithromycin; Biological Transport; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Enzyme Inhibitors; Erythromycin; Humans; Intestinal Mucosa; Intestines; Metabolic Clearance Rate; Models, Biological; Time Factors | 2006 |
Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Drug Design; Erythromycin; Ethers; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Models, Chemical; Oximes | 2006 |
Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Erythromycin; Humans; Infant; Whooping Cough | 2005 |
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae | 2006 |
Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications.
Topics: Anti-Bacterial Agents; Azithromycin; Binding, Competitive; Brucella; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptide Elongation Factor Tu; Phylogeny; Polymorphism, Genetic; Protein Isoforms; Ribosomal Proteins; Ribosomes; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2006 |
Effect of macrolide antibiotics on uptake of digoxin into rat liver.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biological Transport; Blood Flow Velocity; Cardiotonic Agents; Clarithromycin; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Hepatocytes; Josamycin; Liver; Macrolides; Male; Permeability; Rats; Rats, Sprague-Dawley; Roxithromycin; Tissue Distribution | 2007 |
The emergence of drug-resistant Streptococcus pneumoniae and host risk factors for carriage of drug-resistant genes in northeastern Japan.
Topics: Bacterial Proteins; Carrier State; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Japan; Membrane Proteins; Meropenem; Microbial Sensitivity Tests; Nasopharynx; Penicillin-Binding Proteins; Penicillins; Respiratory Tract Infections; Risk Factors; Streptococcus pneumoniae; Thienamycins | 2007 |
Macrolide antibiotics promote the LPS-induced upregulation of prostaglandin E receptor EP2 and thus attenuate macrolide suppression of IL-6 production.
Topics: Analysis of Variance; Animals; Cell Line; Chemokine CXCL2; Clarithromycin; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythromycin; Gene Expression; Interleukin-6; Lipopolysaccharides; Macrophages; Monokines; Receptors, Prostaglandin E; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Up-Regulation | 2007 |
Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Bronchoalveolar Lavage; Clarithromycin; Erythromycin; Female; Horses; Lung; Male | 2007 |
Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Erythromycin; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Rhabdomyolysis; Simvastatin | 2007 |
[Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Topics: Azithromycin; Bacterial Proteins; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Membrane Proteins; Methicillin Resistance; Methyltransferases; Microscopy, Electron, Scanning; Miocamycin; Polymerase Chain Reaction; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 2007 |
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Topics: Anti-Bacterial Agents; Area Under Curve; Azithromycin; Bacteremia; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Failure | 2007 |
Role of alpha1-acid glycoprotein in therapeutic antifibrotic effects of imatinib with macrolides in mice.
Topics: Animals; Benzamides; Cells, Cultured; Clarithromycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Fibroblasts; Imatinib Mesylate; Macrolides; Mice; Orosomucoid; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines | 2007 |
A new insight into solid-state conformation of macrolide antibiotics.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Macrolides; Molecular Conformation; Monosaccharides; Roxithromycin; Structure-Activity Relationship | 2008 |
Hypersensitivity to spiramycin with good tolerance of other macrolides.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Hypersensitivity; Erythromycin; Humans; Male; Skin Tests; Spiramycin | 2007 |
Interaction of the macrolide antimicrobial clarithromycin with dissolved humic acid.
Topics: 1-Octanol; Adsorption; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Humic Substances; Hydrogen-Ion Concentration; Osmolar Concentration; Water | 2008 |
Oral erythromycin is ineffective in the treatment of pityriasis rosea.
Topics: Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Erythromycin; Humans; Pityriasis Rosea; Treatment Outcome | 2008 |
The intracellular accumulation of phagocytic and epithelial cells and the inhibitory effect on Chlamydophila (Chlamydia) pneumoniae of telithromycin and comparator antimicrobials.
Topics: Anti-Bacterial Agents; Cell Line; Chlamydophila pneumoniae; Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Epithelial Cells; Erythromycin; Humans; Ketolides; Microbial Sensitivity Tests; Minocycline; Phagocytes | 2008 |
Synthesis and antibacterial activity of 4''-O-heteroarylcarbamoyl derivatives of macrolide.
Topics: Anti-Bacterial Agents; Carbamates; Chemistry, Pharmaceutical; Clarithromycin; Crystallography, X-Ray; Drug Design; Enterococcus faecalis; Erythromycin; Macrolides; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Chemical; Protein Synthesis Inhibitors | 2008 |
Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients.
Topics: Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Genes, rRNA; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Ribosomes; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2008 |
Cat scratch disease with encephalopathy in a 9-year-old girl.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Bartonella henselae; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cat-Scratch Disease; Cats; Ceftriaxone; Child; Clarithromycin; Drug Therapy, Combination; Encephalitis; Erythromycin; Female; Humans; Lymphadenitis; Minocycline; Thienamycins; Treatment Outcome | 2008 |
National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
Topics: Animals; Anti-Bacterial Agents; Austria; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Health Policy; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Immunization Programs; Incidence; Infant; Male; Meningitis, Pneumococcal; Pneumococcal Infections; Pneumococcal Vaccines; Serotyping; Streptococcus pneumoniae; Vaccination | 2009 |
Synthesis of novel macrolide derivatives with imidazo[4,5-b]pyridinyl sulfur contained alkyl side chains and their antibacterial activity.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Design; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Imidazoles; Ketolides; Macrolides; Microbial Sensitivity Tests; Models, Chemical; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Sulfides; Sulfur | 2009 |
Erythromycin in whooping cough.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Child; Clarithromycin; Erythromycin; Humans; Whooping Cough | 2009 |
[Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Delayed-Action Preparations; Drug Resistance, Multiple, Bacterial; Drug Utilization; Erythromycin; Humans; Italy; Macrolides; Streptococcal Infections; Streptococcus pyogenes | 2009 |
Macrolide-induced digoxin toxicity: a population-based study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Cardiotonic Agents; Case-Control Studies; Clarithromycin; Comorbidity; Digoxin; Drug Interactions; Erythromycin; Female; Humans; Macrolides; Male; Polypharmacy | 2009 |
Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biological Transport; Chlorocebus aethiops; Clarithromycin; COS Cells; Dogs; Dose-Response Relationship, Drug; Erythromycin; Estrone; Humans; Intestinal Mucosa; Intestines; Kinetics; Macrolides; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Rats; Taurocholic Acid; Transfection | 2009 |
Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006).
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Clarithromycin; Drug Utilization; Erythromycin; Health Knowledge, Attitudes, Practice; Humans; Influenza, Human; Macrolides; Risk Factors; Seasons; Socioeconomic Factors | 2010 |
[Potential role of macrolides in the treatment of COPD: current evidence. (discussion)].
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Cytokines; Depression, Chemical; Erythromycin; Humans; Immunologic Factors; Inflammation Mediators; Macrolides; Pulmonary Disease, Chronic Obstructive; Receptors, Virus; Risk Assessment | 2009 |
A toddler with facial nodules: a case of idiopathic facial aseptic granuloma.
Topics: Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Erythromycin; Facial Dermatoses; Granuloma; Humans; Male; Staining and Labeling | 2010 |
Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; United Kingdom; Young Adult | 2010 |
Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Child; Child, Preschool; China; Clarithromycin; DNA Fingerprinting; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Point Mutation; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 23S; Tetracyclines | 2010 |
Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azithromycin; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Bacterial; Epithelium; Erythromycin; Female; Horses; Ketolides; Linear Models; Lung; Macrolides; Male; Microbial Sensitivity Tests; Rhodococcus equi | 2010 |
Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Diffusion; Erythromycin; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Proteus; Staphylococcus aureus | 2011 |
The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Calcium Channel Blockers; Case-Control Studies; Clarithromycin; Cross-Over Studies; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Humans; Hypotension; Macrolides; Male; Matched-Pair Analysis; Ontario; Patient Admission | 2011 |
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Survival; Cells, Cultured; Chemokines; Clarithromycin; Cytokines; Erythromycin; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Roxithromycin; Sputum | 2011 |
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum | 2011 |
Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints.
Topics: Age Factors; Anti-Bacterial Agents; Bayes Theorem; Bias; Clarithromycin; Clinical Trials as Topic; Clinical Trials, Phase IV as Topic; Computer Simulation; Erythromycin; Humans; Macrolides; Models, Statistical; Monte Carlo Method; Pharyngitis; Probability; Research Design; Streptococcus; Treatment Outcome | 2011 |
[Detection and the antibiotic susceptibility analysis of mycoplasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia; Chlamydia Infections; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Infertility, Female; Josamycin; Microbial Sensitivity Tests; Minocycline; Mycoplasma; Mycoplasma Infections; Roxithromycin; Spectinomycin; Tetracycline; Ureaplasma urealyticum; Urogenital System; Young Adult | 2011 |
Investigating the barriers to bioavailability of macrolide antibiotics in the rat.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Clarithromycin; Erythromycin; Hepatocytes; Ketolides; Macrolides; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Roxithromycin | 2012 |
Investigation of drug-drug interaction via mechanism-based inhibition of cytochrome P450 3A by macrolides in dexamethasone-treated female rats.
Topics: Animals; Area Under Curve; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexamethasone; Drug Interactions; Erythromycin; Female; Humans; Male; Microsomes, Liver; Midazolam; Models, Biological; Rats; Sex Factors; Species Specificity | 2012 |
[The effects of macrolides (EM900, clarithromycin and azithromycin) on IL-17-induced IL-8 production by airway epithelial cells].
Topics: Anti-Inflammatory Agents; Azithromycin; Cells, Cultured; Clarithromycin; Erythromycin; Humans; Interleukin-17; Interleukin-8; Recombinant Proteins; Respiratory Mucosa | 2009 |
[14-membered ring macrolides exaggerate IL-10 expression stimulated by LPS].
Topics: Animals; Cells, Cultured; Clarithromycin; Erythromycin; Interleukin-10; Lipopolysaccharides; Macrolides; Macrophages; Mice | 2009 |
[Effects of macrolides in preventing influenza and airway inflammation].
Topics: Clarithromycin; Erythromycin; Humans; In Vitro Techniques; Inflammation; Influenza A virus; Influenza, Human; Macrolides; Respiratory Mucosa | 2009 |
Macrolides for acute lung injury.
Topics: Acute Lung Injury; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Clarithromycin; Erythromycin; Female; Humans; Macrolides; Male; Pentoxifylline | 2012 |
Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis.
Topics: Animals; Anti-Bacterial Agents; Bacteroidaceae Infections; Clarithromycin; Dental Plaque; Dog Diseases; Dogs; Drug Resistance, Bacterial; Erythromycin; Female; Fusobacterium; Fusobacterium Infections; Hemagglutination Inhibition Tests; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Periodontitis; Porphyromonas | 2012 |
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Bronchiolitis; Bronchoalveolar Lavage Fluid; Cell Line; Clarithromycin; Cystic Fibrosis; Drug Interactions; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-6; Lipopolysaccharides; Lung; Macrolides; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moraxella catarrhalis; Neutrophils; Rats; Rats, Sprague-Dawley; Streptococcus | 2012 |
Calcium channel blockers + macrolides: elderly patients hospitalised for low blood pressure.
Topics: Aged; Anti-Bacterial Agents; Calcium Channel Blockers; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Hospitalization; Humans; Hypotension; Macrolides | 2012 |
Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Attention; Azithromycin; Canada; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Mutation; Pneumococcal Infections; Streptococcus pneumoniae | 2013 |
Safety of macrolides during pregnancy.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Female; Heart Defects, Congenital; Humans; Logistic Models; Macrolides; Pregnancy; Prenatal Exposure Delayed Effects; Pyloric Stenosis; Risk | 2013 |
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; DNA Mutational Analysis; Drug Resistance, Bacterial; Erythromycin; Female; Gambia; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Nitroreductases; RNA, Ribosomal, 16S; Tetracycline | 2013 |
Synthesis and antibacterial activity of 9-oxime ether non-ketolides, and novel binding mode of alkylides with bacterial rRNA.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Ether; Ketolides; Models, Molecular; Oximes; RNA, Bacterial; RNA, Ribosomal | 2013 |
Mechanism-based inhibition profiles of erythromycin and clarithromycin with cytochrome P450 3A4 genetic variants.
Topics: Clarithromycin; Cytochrome P-450 CYP3A; Erythromycin; Steroid Hydroxylases | 2013 |
Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells.
Topics: Animals; Apoptosis; Autophagy; Azithromycin; Boronic Acids; Bortezomib; Cell Line, Tumor; Clarithromycin; Endoplasmic Reticulum Stress; Erythromycin; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Macrolides; Mice; Multiple Myeloma; Pyrazines; Transcription Factor CHOP | 2013 |
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Azithromycin; Cause of Death; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Retrospective Studies; Rhabdomyolysis | 2013 |
Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Disease Progression; Doxycycline; Erythromycin; Female; Humans; Longitudinal Studies; Male; Middle Aged; Oxytetracycline; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Sex Factors; United Kingdom | 2013 |
Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Gentamicins; Horse Diseases; Horses; Macrolides; Microbial Sensitivity Tests; Mutation; Rhodococcus equi; Rifampin; Vancomycin | 2013 |
Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Biotransformation; Breath Tests; Chromatography, Liquid; Clarithromycin; Cystic Fibrosis; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Genetic Association Studies; Humans; Male; Polymorphism, Single Nucleotide; Prospective Studies; Risk Assessment; Tandem Mass Spectrometry; Treatment Failure | 2014 |
Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Clarithromycin; Cytokines; Disease Models, Animal; Disease Progression; Drug Design; Epithelial Cells; Erythromycin; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Josamycin; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Spiramycin; Survival Rate | 2014 |
Effects of macrolide antibiotics on rat embryonic heart function in vitro.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Bradycardia; Clarithromycin; Dose-Response Relationship, Drug; Embryo Culture Techniques; Erythromycin; Female; Heart; Macrolides; Male; Rats; Rats, Sprague-Dawley; Teratogens | 2014 |
Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.
Topics: Azithromycin; Chromatography, Liquid; Clarithromycin; Drinking Water; Environmental Monitoring; Erythromycin; Ibuprofen; Pharmaceutical Preparations; Spain; Sulfamethoxazole; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2014 |
Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Propensity Score; Retrospective Studies; Treatment Outcome | 2014 |
Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges".
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Proliferation; Cell Survival; Clarithromycin; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Erythromycin; Female; Gene Expression; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Nude; Molecular Targeted Therapy; Tumor Burden; Verapamil; Xenograft Model Antitumor Assays | 2015 |
Group determination of 14-membered macrolide antibiotics and azithromycin using antibodies against common epitopes.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Azithromycin; Body Fluids; Cattle; Clarithromycin; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Epitopes; Erythromycin; Food Contamination; Humans; Limit of Detection; Macrolides; Rabbits; Roxithromycin; Water Pollutants, Chemical | 2015 |
Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance?
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Doxycycline; Drug Prescriptions; Epidemics; Erythromycin; Humans; Mycoplasma pneumoniae; Norway; Pneumonia, Mycoplasma; Public Health Surveillance | 2015 |
Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Mycoplasma pneumoniae; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Young Adult | 2015 |
Novel macrolide-resistance genes, mef(C) and mph(G), carried by plasmids from Vibrio and Photobacterium isolated from sediment and seawater of a coastal aquaculture site.
Topics: Animals; Anti-Bacterial Agents; Aquatic Organisms; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Genes, Bacterial; Geologic Sediments; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Phosphotransferases; Photobacterium; Plasmids; Seawater; Vibrio | 2015 |
Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cells, Cultured; Clarithromycin; Erythromycin; Goblet Cells; Humans; In Vitro Techniques; Lipopolysaccharides; Mucin 5AC; Mucus; Nasal Mucosa; Rats; Respiratory Mucosa; RNA, Messenger; Tumor Necrosis Factor-alpha | 2015 |
Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Japan; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Mutation; RNA, Ribosomal, 23S | 2015 |
Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cardiotoxins; Clarithromycin; Cytochromes c; Erythromycin; In Vitro Techniques; Macrolides; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondria, Liver; Mitochondrial Swelling; Myocytes, Cardiac; Rats, Wistar; Reactive Oxygen Species; Succinate Dehydrogenase | 2016 |
Underlying mechanism of drug-drug interaction between pioglitazone and gemfibrozil: Gemfibrozil acyl-glucuronide is a mechanism-based inhibitor of CYP2C8.
Topics: Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inhibitors; Drug Interactions; Erythromycin; Gemfibrozil; Glucuronides; Glucuronosyltransferase; Humans; Hypolipidemic Agents; Microsomes, Liver; Pioglitazone; Thiazolidinediones | 2015 |
Use of macrolides during pregnancy and the risk of birth defects: a population-based study.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Erythromycin; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Macrolides; Penicillins; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Quebec; Registries; Risk Factors | 2015 |
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines.
Topics: Apoptosis; Autophagy; Azithromycin; Cell Line, Tumor; Clarithromycin; Drug Synergism; ErbB Receptors; Erythromycin; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Macrolides; Pancreatic Neoplasms; Quinazolines | 2016 |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Cohort Studies; Erythromycin; Female; Humans; Logistic Models; Macrolides; Male; Ontario; Propensity Score; Retrospective Studies; Risk Assessment; Risk Factors | 2016 |
Macrolides use and the risk of sudden cardiac death.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Coronary Artery Disease; Coronary Disease; Death, Sudden, Cardiac; Erythromycin; Humans; Macrolides; Plaque, Atherosclerotic; Risk Factors; Torsades de Pointes | 2016 |
Reduced persistence of the macrolide antibiotics erythromycin, clarithromycin and azithromycin in agricultural soil following several years of exposure in the field.
Topics: Agriculture; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Environmental Monitoring; Environmental Pollution; Erythromycin; Macrolides; Soil; Soil Pollutants; Waste Disposal, Fluid | 2016 |
Inducible Expression of both ermB and ermT Conferred High Macrolide Resistance in Streptococcus gallolyticus subsp. pasteurianus Isolates in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Streptococcus gallolyticus; Virulence | 2016 |
Comparison of antibiotic regimens in preterm premature rupture of membranes: neonatal morbidity and 2-year follow-up of neurologic outcome.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Pregnancy; Pregnancy Outcome; Retrospective Studies; Time Factors | 2017 |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; United Kingdom | 2017 |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Clarithromycin; Erythromycin; Humans; Macrolides; Pharmacogenetics; Signal Transduction | 2017 |
Effect of biofilm formation by clinical isolates of
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biofilms; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; Tetracycline | 2017 |
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atrial Fibrillation; Azithromycin; Cardiotonic Agents; Case-Control Studies; Cefuroxime; Clarithromycin; Death, Sudden; Digoxin; Drug Interactions; Erythromycin; Female; Heart Failure; Humans; Macrolides; Male; Ontario; Risk Factors | 2017 |
Removal of antibiotics during the anaerobic digestion of pig manure.
Topics: Anaerobiosis; Animals; Anti-Bacterial Agents; Biodegradation, Environmental; Biofuels; Clarithromycin; Erythromycin; Manure; Methane; Sulfadiazine; Sulfamethizole; Swine; Waste Disposal, Fluid | 2017 |
Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Ketolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2017 |
Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Proteins; Bulgaria; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Macrolides; Male; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Multiplex Polymerase Chain Reaction; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2017 |
Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Helicobacter Infections; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Stroke; Time Factors; United Kingdom | 2018 |
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Czech Republic; Erythromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough; Young Adult | 2017 |
The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Sputum; Time Factors | 2018 |
Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Child; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Ear, Middle; Erythromycin; Female; Gene Expression; Genotype; Humans; Male; Membrane Proteins; Methylation; Microbial Sensitivity Tests; Nasopharynx; Phenotype; Ribosomes; Streptococcal Infections; Streptococcus pyogenes; Vagina | 2016 |
The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Ear, Middle; Erythromycin; Guinea Pigs; Histamine; Otitis Media with Effusion; Roxithromycin | 2018 |
Oxidative stress responses and cellular energy allocation changes in microalgae following exposure to widely used human antibiotics.
Topics: Animals; Anti-Bacterial Agents; Catalase; Chlorophyta; Ciprofloxacin; Clarithromycin; Energy Metabolism; Environmental Exposure; Erythromycin; Humans; Lipid Peroxidation; Microalgae; Oxidative Stress; Sulfamethoxazole; Superoxide Dismutase; Water Pollutants, Chemical | 2018 |
Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Equidae; Erythromycin; Feces; Horses; Kentucky; Microbial Sensitivity Tests; Musculoskeletal Diseases; Prevalence; Respiratory System; Rhodococcus equi; Rifampin; Soft Tissue Infections | 2019 |
Anti-Inflammatory Effects of EM900 on Cultured Human Nasal Epithelial Cells.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Clarithromycin; Epithelial Cells; Erythromycin; Humans; Inflammation Mediators; Interleukin-8; Nasal Mucosa; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2018 |
Efficacy of macrolides on gastric motility in extremely low birth weight infants.
Topics: Clarithromycin; Enteral Nutrition; Erythromycin; Female; Food Intolerance; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Retrospective Studies; Treatment Outcome | 2019 |
Validation of a liquid chromatography coupled with tandem mass spectrometry method for the determination of drugs in wastewater using a three-phase solvent system.
Topics: Amoxicillin; Carbamazepine; Chromatography, Liquid; Clarithromycin; Erythromycin; Metformin; Particle Size; Solvents; Surface Properties; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2020 |
Antimicrobial susceptibility patterns of Rhodococcus equi from necropsied foals with rhodococcosis.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Horse Diseases; Horses; Microbial Sensitivity Tests; Rhodococcus equi | 2020 |
The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Infant; Japan; Macrolides; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; RNA, Ribosomal, 23S; Whooping Cough | 2020 |
Comparative Study of the Effect of Macrolide Antibiotics Erythromycin, Clarithromycin, and Azithromycin on the ERG1 Gene Expression in H9c2 Cardiomyoblast Cells.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Carrier Proteins; Cell Proliferation; Cell Survival; Clarithromycin; Erythromycin; Gene Expression; Heart; Macrolides; Membrane Proteins; Myoblasts, Cardiac; Rats | 2020 |
The Safety of Delayed Versus Immediate Antibiotic Prescribing for Upper Respiratory Tract Infections.
Topics: Anti-Bacterial Agents; Clarithromycin; Doxycycline; Erythromycin; Humans; Inappropriate Prescribing; Practice Patterns, Physicians'; Respiratory Tract Infections | 2021 |
Sensitivity of VCD spectroscopy for small structural and stereochemical changes of macrolide antibiotics.
Topics: Anti-Bacterial Agents; Circular Dichroism; Clarithromycin; Density Functional Theory; Erythromycin; Molecular Conformation; Stereoisomerism; Vibration | 2020 |
Direct anti-biofilm effects of macrolides on Acinetobacter baumannii: comprehensive and comparative demonstration by a simple assay using microtiter plate combined with peg-lid.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acyl-Butyrolactones; Agrobacterium tumefaciens; Anti-Bacterial Agents; Azithromycin; Biofilms; Biological Assay; Clarithromycin; Erythromycin; Fidaxomicin; Humans; Ivermectin; Josamycin; Microbial Sensitivity Tests; Microbial Viability; Quorum Sensing; Spiramycin | 2020 |
Clarithromycin Inhibits Pneumolysin Production via Downregulation of
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Disease Models, Animal; Down-Regulation; Erythromycin; Humans; Lincosamides; Male; Mice; Mice, Inbred BALB C; Pneumonia; Protein Synthesis Inhibitors; Streptococcus pneumoniae; Streptolysins; Transcription, Genetic | 2021 |
SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant
Topics: Animals; Antimicrobial Cationic Peptides; Biofilms; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2022 |
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure.
Topics: Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Colchicine; Erythromycin; Humans; Macrolides; Male | 2022 |
Predicting selection for antimicrobial resistance in UK wastewater and aquatic environments: Ciprofloxacin poses a significant risk.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; United Kingdom; Wastewater; Water Pollutants, Chemical | 2022 |
Risk ranking of macrolide antibiotics - Release levels, resistance formation potential and ecological risk.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Humans; Macrolides | 2023 |
Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Microbial Sensitivity Tests | 2023 |
[Pollution Characteristics and Risk Assessment of Antibiotics in Beiyun River Basin in Beijing].
Topics: Anti-Bacterial Agents; Azithromycin; Beijing; Clarithromycin; Erythromycin; Lincomycin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sulfapyridine; Tandem Mass Spectrometry | 2023 |